☰

Michael S. Gold, Ph.D. - Publications

Affiliations: 
2002 University of California, Los Angeles, Los Angeles, CA 
Area:
Personality, drug abuse, psychometrics, structural equation modeling, factor analysis, reliability theory
Tree Info Grants Similar researchers PubMed Report error

2/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Gold MS, Bentler PM, Kim KH. A Comparison of Maximum-Likelihood and Asymptotically Distribution-Free Methods of Treating Incomplete Nonnormal Data Structural Equation Modeling: a Multidisciplinary Journal. 10: 47-79. DOI: 10.1207/S15328007Sem1001_3  0.433
2000 Gold MS, Bentler PM. Treatments of Missing Data: A Monte Carlo Comparison of RBHDI, Iterative Stochastic Regression Imputation, and Expectation-Maximization Structural Equation Modeling. 7: 319-355. DOI: 10.1207/S15328007Sem0703_1  0.443
Low-probability matches (unlikely to be authored by this person)
1983 Gold MS, Pottash AC, Sweeney D, Martin D, Extein I. Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence. Annals of the New York Academy of Sciences. 398: 140-50. PMID 6961853 DOI: 10.1111/j.1749-6632.1982.tb39488.x  0.173
1984 Gold MS, Dackis CA, Washton AM. The sequential use of clonidine and naltrexone in the treatment of opiate addicts. Advances in Alcohol & Substance Abuse. 3: 19-39. PMID 6388273 DOI: 10.1300/J251V03N03_03  0.168
2011 Avena NM, Bocarsly ME, Hoebel BG, Gold MS. Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". Current Drug Abuse Reviews. 4: 133-9. PMID 21999687 DOI: 10.2174/1874473711104030133  0.165
2007 DuPont RL, Gold MS. Comorbidity and "self-medication". Journal of Addictive Diseases. 26: 13-23. PMID 19283971 DOI: 10.1300/J069v26S01_03  0.164
1989 Herridge P, Gold MS. Pharmacological adjuncts in the treatment of opioid and cocaine addicts. Journal of Psychoactive Drugs. 20: 233-42. PMID 3069983 DOI: 10.1080/02791072.1988.10472494  0.163
2015 Blum K, Liu Y, Wang W, Wang Y, Zhang Y, Oscar-Berman M, Smolen A, Febo M, Han D, Simpatico T, Cronjé FJ, Demetrovics Z, Gold MS. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgraduate Medicine. 127: 232-41. PMID 25526228 DOI: 10.1080/00325481.2015.994879  0.162
1994 Extein IL, Gold MS. Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence. Journal of Addictive Diseases. 12: 29-43. PMID 7504527 DOI: 10.1300/J069V12N03_04  0.162
2021 Blum K, Bowirrat A, Braverman ER, Baron D, Cadet JL, Kazmi S, Elman I, Thanos PK, Badgaiyan RD, Downs WB, Bagchi D, Llanos-Gomez L, Gold MS. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International Journal of Environmental Research and Public Health. 18. PMID 34770047 DOI: 10.3390/ijerph182111529  0.16
2017 Blum K, Gold M, Demetrovics Z, Archer T, Thanos PK, Baron D, Badgaiyan RD. Substance use disorder a bio-directional subset of reward deficiency syndrome. Frontiers in Bioscience (Landmark Edition). 22: 1534-1548. PMID 28410131 DOI: 10.2741/4557  0.16
2021 Lee YK, Gold MS, Fuehrlein BS. Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder. Journal of the Neurological Sciences. 432: 120094. PMID 34933249 DOI: 10.1016/j.jns.2021.120094  0.159
2014 Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS. Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs. Plos One. 9: e104275. PMID 25247439 DOI: 10.1371/journal.pone.0104275  0.159
2013 Bocarsly ME, Murray SM, Gold MS, Avena NM. Food-specific addictions: brain mechanisms and pharmacological treatment approaches F1000research. 4. DOI: 10.7490/F1000Research.1093205.1  0.157
2016 Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M. A REVIEW OF KETAMINE ABUSE AND DIVERSION. Depression and Anxiety. PMID 27328618 DOI: 10.1002/da.22536  0.154
2020 Blum K, Lott L, Baron D, Smith DE, Badgaiyan RD, Gold MS. Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual. Journal of Systems and Integrative Neuroscience. 7. PMID 32934823 DOI: 10.15761/JSIN.1000229  0.154
2016 Beitscher-Campbell H, Blum K, Febo M, Madigan MA, Giordano J, Badgaiyan RD, Braverman ER, Dushaj K, Li M, Gold MS. Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic. Journal of Behavioral Addictions. 1-9. PMID 27502054 DOI: 10.1556/2006.5.2016.055  0.154
2011 Blum K, Gold MS. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: A hypothesis Medical Hypotheses. 76: 576-584. PMID 21306831 DOI: 10.1016/j.mehy.2011.01.005  0.154
2020 Patterson Silver Wolf DA, Gold M. Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. Journal of the Neurological Sciences. 411: 116718. PMID 32078842 DOI: 10.1016/j.jns.2020.116718  0.154
2018 Baron D, Blum K, Chen A, Gold M, Badgaiyan RD. Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis. The Journal of the American Osteopathic Association. 118: 115-118. PMID 29379966 DOI: 10.7556/jaoa.2018.026  0.153
2017 Blum K, Han D, Modestino EJ, Saunders S, Roy AK, Jacobs W, Inaba DS, Baron D, Oscar-Berman M, Hauser M, Badgaiyan RD, Smith DE, Femino J, Gold MS. A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Substance Use & Misuse. 1-10. PMID 29257919 DOI: 10.1080/10826084.2017.1400064  0.151
2005 Bruijnzeel AW, Repetto M, Gold MS. Neurobiological mechanisms in addictive and psychiatric disorders. The Psychiatric Clinics of North America. 27: 661-74. PMID 15550286 DOI: 10.1016/J.PSC.2004.06.005  0.15
2015 Kobeissy F, Mouhieddine TH, Nokkari A, Itani M, Mouhieddine M, Zhang Z, Zhu R, Gold MS, Wang KK, Mechref Y. Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA Translational Proteomics. 3: 381-52. DOI: 10.1016/J.Trprot.2014.04.001  0.149
2011 Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, Braverman E, Gold M. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. Journal of Genetic Syndromes & Gene Therapy. 2012. PMID 23483116 DOI: 10.4172/2157-7412.S2-001  0.148
2013 Gold MS, Avena NM. Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating. Biological Psychiatry. 74: e11. PMID 23726509 DOI: 10.1016/J.Biopsych.2013.04.022  0.148
2015 Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? Molecular Neurobiology. 52: 1862-9. PMID 25750061 DOI: 10.1007/S12035-015-9110-9  0.148
2013 Blum K, Foster Olive M, Wang KK, Febo M, Borsten J, Giordano J, Hauser M, Gold MS. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Medical Hypotheses. 81: 450-5. PMID 23845561 DOI: 10.1016/J.Mehy.2013.06.007  0.147
2010 Kobeissy FH, Sadasivan S, Buchanan M, Zhang Z, Gold MS, Wang KK. Methods in systems biology of experimental methamphetamine drug abuse. Methods in Molecular Biology (Clifton, N.J.). 662: 303-16. PMID 20824478 DOI: 10.1007/978-1-60761-800-3_15  0.147
2017 Blum K, Gold MS, Jacobs W, McCall WV, Febo M, Baron D, Dushaj K, Demetrovics Z, Badgaiyan RD. Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause. Frontiers in Bioscience (Landmark Edition). 22: 1247-1288. PMID 28199203 DOI: 10.2741/4544  0.146
2020 Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: A concise review. Journal of the Neurological Sciences. 411: 116719. PMID 32070807 DOI: 10.1016/J.Jns.2020.116719  0.146
2012 Kobeissy FH, Mitzelfelt JD, Fishman I, Morgan D, Gaskins R, Zhang Z, Gold MS, Wang KK. Methods in drug abuse models: comparison of different models of methamphetamine paradigms. Methods in Molecular Biology (Clifton, N.J.). 829: 269-78. PMID 22231820 DOI: 10.1007/978-1-61779-458-2_17  0.144
1981 Gold MS, Pottash ALC, Extein I, Martin DA, Finn LB, Sweeney DR, Kleber HD. Evidence for an endorphin dysfunction in methadone addicts: Lack of ACTH response to naloxone Drug and Alcohol Dependence. 8: 257-262. PMID 6276118 DOI: 10.1016/0376-8716(81)90069-7  0.144
2021 Browne T, Gold MS, Martin DM. The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19 Current Psychopharmacology. 10: 138-154. DOI: 10.2174/2211556010666210125124645  0.143
1993 Miller NS, Gold MS. A neurochemical basis for alcohol and other drug addiction. Journal of Psychoactive Drugs. 25: 121-8. PMID 8377079 DOI: 10.1080/02791072.1993.10472241  0.143
2007 Svetlov SI, Kobeissy FH, Gold MS. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. Journal of Addictive Diseases. 26: 1-6. PMID 18032226 DOI: 10.1300/J069V26N04_01  0.143
2013 Avena NM, Murray S, Gold MS. Comparing the effects of food restriction and overeating on brain reward systems. Experimental Gerontology. 48: 1062-7. PMID 23535488 DOI: 10.1016/J.Exger.2013.03.006  0.143
2016 Blum K, Gold M, Clark HW, Dushaj K, Badgaiyan RD. Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment? Substance Use & Misuse. 1-6. PMID 27462930 DOI: 10.1080/10826084.2016.1200097  0.143
2018 Blum K, Gondré-Lewis M, Steinberg B, Elman I, Baron D, Modestino EJ, Badgaiyan RD, Gold MS. Our evolved unique pleasure circuit makes humans different from apes: Reconsideration of data derived from animal studies. Journal of Systems and Integrative Neuroscience. 4. PMID 30956812 DOI: 10.15761/JSIN.1000191  0.142
2014 Wang Y, Wang H, Li W, Zhu J, Gold MS, Zhang D, Wang L, Li Y, Yan X, Cheng J, Li Q, Wang W. Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment. Neuroscience Letters. 581: 120-4. PMID 25157798 DOI: 10.1016/J.Neulet.2014.08.026  0.141
2020 Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakocevic DB, Loukianova LL, Hall-Flavin DK, Gentry MT, Rummans TA, Chauhan M, Gold MS. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clinic Proceedings. 95: 2709-2718. PMID 33276843 DOI: 10.1016/j.mayocp.2020.10.011  0.14
1990 Miller NS, Gold MS, Pottash AC. A 12-step treatment approach for marijuana (Cannabis) dependence. Journal of Substance Abuse Treatment. 6: 241-50. PMID 2687482 DOI: 10.1016/0740-5472(89)90048-2  0.139
1989 Miller NS, Gold MS. The diagnosis of marijuana (cannabis) dependence. Journal of Substance Abuse Treatment. 6: 183-92. PMID 2677398 DOI: 10.1016/0740-5472(89)90005-6  0.138
2021 Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK, Elman I, Badgaiyan RD, Bowirrat A, Gold MS. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Journal of Personalized Medicine. 11. PMID 33809702 DOI: 10.3390/jpm11030212  0.138
1980 Gold MS. Opiate Withdrawal Using Clonidine Jama. 243: 343. DOI: 10.1001/Jama.1980.03300300021018  0.138
2006 Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Pomm R, Frost-Pineda K. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. Journal of Addictive Diseases. 25: 15-21. PMID 16597569 DOI: 10.1300/J069v25n01_04  0.137
1995 Miller NS, Gold MS. Dissociation of "conscious desire" (craving) from and relapse in alcohol and cocaine dependence. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 6: 99-106. PMID 7804394 DOI: 10.3109/10401239409148988  0.137
1990 Miller NS, Gold MS. The Disease and Adaptive Models of Addiction: A Re-Evaluation Journal of Drug Issues. 20: 29-35. DOI: 10.1177/002204269002000102  0.137
2020 Blum K, Cadet JL, Gold MS. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. Journal of the Neurological Sciences. 420: 117252. PMID 33279726 DOI: 10.1016/j.jns.2020.117252  0.137
2021 Moran M, Blum K, Ponce JV, Lott L, Gondré-Lewis MC, Badgaiyan S, Brewer R, Downs BW, Fynman P, Weingarten A, Cadet JL, Smith DE, Baron D, Thanos PK, Modestino EJ, ... ... Gold MS, et al. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial. Molecular Neurobiology. PMID 33683627 DOI: 10.1007/s12035-021-02312-1  0.137
1991 Miller NS, Gold MS. Benzodiazepines: a major problem. Introduction. Journal of Substance Abuse Treatment. 8: 3-7. PMID 1675690 DOI: 10.1016/0740-5472(91)90021-2  0.136
2015 Blum K, Thompson B, Demotrovics Z, Femino J, Giordano J, Oscar-Berman M, Teitelbaum S, Smith DE, Roy AK, Agan G, Fratantonio J, Badgaiyan RD, Gold MS. The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. Journal of Reward Deficiency Syndrome. 1: 46-64. PMID 26306329 DOI: 10.17756/jrds.2015-008  0.135
2008 Kobeissy FH, Sadasivan S, Liu J, Gold MS, Wang KK. Psychiatric research: psychoproteomics, degradomics and systems biology. Expert Review of Proteomics. 5: 293-314. PMID 18466058 DOI: 10.1586/14789450.5.2.293  0.133
1986 Estroff TW, Gold MS. Medical and psychiatric complications of cocaine abuse with possible points of pharmacological treatment. Advances in Alcohol & Substance Abuse. 5: 61-76. PMID 3832901 DOI: 10.1300/J251V05N01_05  0.133
2015 Li Q, Li W, Wang H, Wang Y, Zhang Y, Zhu J, Zheng Y, Zhang D, Wang L, Li Y, Yan X, Chang H, Fan M, Li Z, Tian J, ... Gold MS, et al. Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related functional magnetic resonance imaging study. Addiction Biology. 20: 968-78. PMID 25214465 DOI: 10.1111/Adb.12182  0.133
1985 Washton AM, Gold MS, Pottash AC. Opiate and cocaine dependencies. Techniques to help counter the rising tide. Postgraduate Medicine. 77: 293-7, 300. PMID 3983028 DOI: 10.1080/00325481.1985.11698968  0.132
1987 Jonas JM, Gold MS. Treatment of antidepressant-resistant bulimia with naltrexone. International Journal of Psychiatry in Medicine. 16: 305-9. PMID 3557806 DOI: 10.2190/0CMP-4XXH-3641-NRDW  0.132
2021 Blum K, McLaughlin T, Modestino EJ, Baron D, Bowirrat A, Brewer R, Steinberg B, Roy AK, Febo M, Badgaiyan RD, Gold MS. Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling. Current Psychopharmacology. 10. PMID 34707968 DOI: 10.2174/2211556010666210215153513  0.132
2014 Blum K, Oscar-Berman M, Jacobs W, McLaughlin T, Gold MS. Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)? Journal of Addiction Research & Therapy. 5. PMID 25664200 DOI: 10.4172/2155-6105.1000185  0.131
2014 Blum K, Thanos PK, Gold MS. Dopamine and glucose, obesity, and reward deficiency syndrome. Frontiers in Psychology. 5: 919. PMID 25278909 DOI: 10.3389/Fpsyg.2014.00919  0.131
2015 Blum K, Badgaiyan RD, Gold MS. Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics. Cureus. 7: e348. PMID 26623203 DOI: 10.7759/cureus.348  0.131
2021 Makarczyk MJ, Gao Q, He Y, Li Z, Gold MS, Hochberg M, Bunnell B, Tuan RS, Goodman SB, Lin H. Current Models for Development of Disease-Modifying Osteoarthritis Drugs. Tissue Engineering. Part C, Methods. PMID 33403944 DOI: 10.1089/ten.TEC.2020.0309  0.13
2013 Blum K, Oscar-Berman M, Barh D, Giordano J, Gold M. Dopamine Genetics and Function in Food and Substance Abuse. Journal of Genetic Syndromes & Gene Therapy. 4. PMID 23543775 DOI: 10.4172/2157-7412.1000121  0.13
1988 Miller NS, Dackis CA, Gold MS. The relationship of addiction, tolerance, and dependence to alcohol and drugs: a neurochemical approach. Journal of Substance Abuse Treatment. 4: 197-207. PMID 3325655 DOI: 10.1016/S0740-5472(87)80014-4  0.13
2015 McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, Fratantonio JL, Simpatico T, Gold MS. Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: Role of enhanced brain reward functional connectivity and homeostasis redeeming joy. Journal of Behavioral Addictions. 4: 106-115. PMID 26132915 DOI: 10.1556/2006.4.2015.008  0.129
2014 Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). Molecular Neurobiology. 50: 765-96. PMID 24878765 DOI: 10.1007/s12035-014-8726-5  0.129
2006 McAuliffe PF, Gold MS, Bajpai L, Merves ML, Frost-Pineda K, Pomm RM, Goldberger BA, Melker RJ, Cendán JC. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Medical Hypotheses. 66: 874-82. PMID 16431033 DOI: 10.1016/j.mehy.2005.10.030  0.129
2013 Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/J.Jalz.2012.03.003  0.129
2012 Avena NM, Gearhardt AN, Gold MS, Wang GJ, Potenza MN. Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data. Nature Reviews. Neuroscience. 13: 514; author reply 51. PMID 22714023 DOI: 10.1038/Nrn3212-C1  0.129
2020 Wiss DA, Avena N, Gold M. Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications. Nutrients. 12. PMID 33207612 DOI: 10.3390/nu12113521  0.129
1979 Kleber HD, Gold MS. Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Annals of the New York Academy of Sciences. 311: 81-98. PMID 33588 DOI: 10.1111/J.1749-6632.1978.Tb16767.X  0.129
2022 Dash G, Patil A, Kroumpouzos G, Galadari H, Gold M, Grabbe S, Goldust M. Hormonal Therapies in the Management of Acne Vulgaris. Journal of Drugs in Dermatology : Jdd. 21: 618-623. PMID 35674767 DOI: 10.36849/JDD.6494  0.129
2020 Blum K, Gold M, Modestino EJ, Baron D, Boyett B, Siwicki D, Lott L, Podesta A, Roy AK, Hauser M, Downs BW, Badgaiyan RD. Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)? Journal of Systems and Integrative Neuroscience. 4. PMID 31750006 DOI: 10.15761/JSIN.1000196  0.129
1991 Miller NS, Gold MS, Klahr AL. The diagnosis of alcohol and cannabis dependence (addiction) in cocaine dependence (addiction). The International Journal of the Addictions. 25: 735-44. PMID 2272719 DOI: 10.3109/10826089009056215  0.129
2011 Blum K, Liu Y, Shriner R, Gold MS. Reward circuitry dopaminergic activation regulates food and drug craving behavior Current Pharmaceutical Design. 17: 1158-1167. PMID 21492092  0.128
1993 Miller NS, Summers GL, Gold MS. Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. Journal of Addictive Diseases. 12: 25-35. PMID 8381028 DOI: 10.1300/J069v12n01_03  0.128
2019 Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings. 94: 2072-2086. PMID 31543255 DOI: 10.1016/j.mayocp.2019.03.029  0.128
2020 Brewer R, Blum K, Bowirrat A, Modestino EJ, Baron D, Badgaiyan RD, Moran M, Boyett B, Gold MS. Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia Current Psychopharmacology. 9: 164-184. DOI: 10.2174/2211556009999200628093231  0.128
2016 Blum K, Febo M, Badgaiyan RD, Demetrovics Z, Simpatico T, Fahlke C, Oscar-Berman M, Li M, Dushaj K, Gold MS. Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape. Current Neuropharmacology. PMID 27174576 DOI: 10.2174/1570159X13666160512150918  0.127
1990 Miller NS, Gold MS, Belkin BM. The diagnosis of alcohol and cannabis dependence in cocaine dependence. Advances in Alcohol & Substance Abuse. 8: 33-42. PMID 2343796 DOI: 10.1300/J251V08N03_03  0.127
1993 Gold MS. Is There a Treatment or Treatments for Drug Abuse or Addiction? Contemporary Psychology: a Journal of Reviews. 38: 1119-1120. DOI: 10.1037/032711  0.127
2005 Bruijnzeel AW, Gold MS. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Research. Brain Research Reviews. 49: 505-28. PMID 16269317 DOI: 10.1016/j.brainresrev.2005.01.007  0.127
1991 Miller NS, Belkin BM, Gold MS. Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment. Comprehensive Psychiatry. 32: 153-65. PMID 2022115 DOI: 10.1016/0010-440X(91)90008-Z  0.127
1990 Miller NS, Gold MS. Benzodiazepines: tolerance, dependence, abuse, and addiction. Journal of Psychoactive Drugs. 22: 23-33. PMID 1969940 DOI: 10.1080/02791072.1990.10472194  0.127
1999 Gamberino WC, Gold MS. Neurobiology of tobacco smoking and other addictive disorders. The Psychiatric Clinics of North America. 22: 301-12. PMID 10385935 DOI: 10.1016/S0193-953X(05)70078-2  0.127
1989 Miller NS, Millman RB, Gold MS. Amphetamines: Pharmacology, abuse and addiction Advances in Alcohol and Substance Abuse. 8: 53-69. PMID 2546376 DOI: 10.1300/J251v08n02_03  0.126
1995 Miller NS, Gold MS, Stennie K. Benzodiazepines: The Dissociation of Addiction From Pharmacological Dependence/Withdrawal Psychiatric Annals. 25: 149-152. DOI: 10.3928/0048-5713-19950301-07  0.126
1985 Washton AM, Gold MS, Pottash AC. Successful use of naltrexone in addicted physicians and business executives. Advances in Alcohol & Substance Abuse. 4: 89-96. PMID 6524509 DOI: 10.1300/J251V04N02_08  0.126
2015 Schoenthaler SJ, Blum K, Braverman ER, Giordano J, Thompson B, Oscar-Berman M, Badgaiyan RD, Madigan MA, Dushaj K, Li M, Demotrovics Z, Waite RL, Gold MS. NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity. Journal of Reward Deficiency Syndrome. 1: 36-45. PMID 26052556 DOI: 10.17756/jrds.2015-007  0.126
2015 Gold MS, Badgaiyan RD, Blum K. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. The Psychiatric Clinics of North America. 38: 419-62. PMID 26300032 DOI: 10.1016/j.psc.2015.05.011  0.126
2015 Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, Badgaiyan RD, Gardner E, Demetrovics Z, Fahlke C, Haberstick BC, Dushaj K, Gold MS. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. Journal of Reward Deficiency Syndrome. 1: 95-104. PMID 27398406 DOI: 10.17756/jrds.2015-016  0.125
2008 Kobeissy FH, Jeung JA, Warren MW, Geier JE, Gold MS. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Addiction Biology. 13: 15-25. PMID 17910739 DOI: 10.1111/J.1369-1600.2007.00083.X  0.125
1990 Dackis CA, Gold MS. Addictiveness of central stimulants. Advances in Alcohol & Substance Abuse. 9: 9-26. PMID 1974121 DOI: 10.1300/J251V09N01_02  0.124
2015 Blum K, Badgaiyan RD, Gold MS. Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics. CurēUs. 7: e290. PMID 26251766 DOI: 10.7759/cureus.290  0.124
2015 Blum K, Simpatico T, Badgaiyan RD, Demetrovics Z, Fratantonio J, Agan G, Febo M, Gold MS. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms. Journal of Reward Deficiency Syndrome. 1: 75-80. PMID 27617300 DOI: 10.17756/jrds.2015-012  0.124
1980 Gold MS, Kleber HD. A rationale for opiate withdrawal symptomatology. Drug and Alcohol Dependence. 4: 419-24. PMID 228923 DOI: 10.1016/0376-8716(79)90074-7  0.124
2012 Blum K, Werner T, Carnes S, Carnes P, Bowirrat A, Giordano J, Oscar-Berman M, Gold M. Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms. Journal of Psychoactive Drugs. 44: 38-55. PMID 22641964 DOI: 10.1080/02791072.2012.662112  0.123
2020 Blum K, Baron D, McLaughlin T, Gold MS. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). Journal of the Neurological Sciences. 411: 116733. PMID 32088516 DOI: 10.1016/j.jns.2020.116733  0.123
2011 Zhang Y, von Deneen KM, Tian J, Gold MS, Liu Y. Food addiction and neuroimaging Current Pharmaceutical Design. 17: 1149-1157. PMID 21492080 DOI: 10.2174/138161211795656855  0.122
2018 Gold MS, Blum K, Febo M, Baron D, Modestino EJ, Elman I, Badgaiyan RD. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. Frontiers in Bioscience (Scholar Edition). 10: 309-325. PMID 29293435 DOI: 10.2741/S518  0.122
2015 Blum K, Oscar-Berman M, Braverman ER, Febo M, Li M, Gold MS. Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. Journal of Reward Deficiency Syndrome. 1: 20-23. PMID 26306328 DOI: 10.17756/jrds.2015-005  0.122
2012 Blum K, Gardner E, Oscar-Berman M, Gold M. "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Current Pharmaceutical Design. 18: 113-8. PMID 22236117 DOI: 10.2174/138161212798919110  0.122
1986 Roehrich H, Gold MS. Diagnosis of substance abuse in an adolescent psychiatric population. International Journal of Psychiatry in Medicine. 16: 137-43. PMID 3744682 DOI: 10.2190/HF4R-F6FA-P0WW-KG92  0.122
2007 Gold M, Melker R, Goldberger B. Physician drug addictions: Additional data support the gold hypothesis European Psychiatry. 22: S188. DOI: 10.1016/j.eurpsy.2007.01.621  0.121
2008 Merlo LJ, Gold MS. Prescription opioid abuse and dependence among physicians: hypotheses and treatment. Harvard Review of Psychiatry. 16: 181-94. PMID 18569039 DOI: 10.1080/10673220802160316  0.121
2009 Kobeissy FH, Zhang Z, Sadasivan S, Gold MS, Wang KK. Methods in drug abuse neuroproteomics: methamphetamine psychoproteome. Methods in Molecular Biology (Clifton, N.J.). 566: 217-28. PMID 20058175 DOI: 10.1007/978-1-59745-562-6_15  0.121
2020 Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? Journal of the Neurological Sciences. 418: 117137. PMID 32957037 DOI: 10.1016/j.jns.2020.117137  0.121
2007 Goldberger BA, Graham NA, Nelson SJ, Cadet JL, Gold MS. A marked increase in cocaine-related deaths in the State of Florida: precursor to an epidemic? Journal of Addictive Diseases. 26: 113-6. PMID 18018815 DOI: 10.1300/J069v26n03_13  0.121
1981 Gold MS, Pottash AL, Sweeney DR, Kleber HD. Efficacy of clonidine in opiate withdrawal: a study of thirty patients. Drug and Alcohol Dependence. 6: 201-8. PMID 7023893 DOI: 10.1016/0376-8716(80)90323-3  0.121
1986 Gold MS, Dackis CA, Pottash AL, Extein I, Washton A. Cocaine update: from bench to bedside. Advances in Alcohol & Substance Abuse. 5: 35-60. PMID 3914209 DOI: 10.1300/J251V05N01_04  0.121
2017 Febo M, Blum K, Badgaiyan RD, Baron D, Thanos PK, Colon-Perez LM, Demortrovics Z, Gold MS. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. Frontiers in Bioscience (Landmark Edition). 22: 669-691. PMID 27814639 DOI: 10.2741/4509  0.12
2024 Cox SE, Kaufman-Janette J, Cohen JL, Gold M, Joseph J, Nestor MS, Rzany B, Taylor S, Zhou J, Cecerle M, Pueraro E, Irvine R, Dayan S. LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 38470985 DOI: 10.1097/DSS.0000000000004152  0.12
2024 Gold M, Abdulla S, Andriessen A, Bucay V, Haus A, Xiaolei Q, Schlesinger T, Song W, Zhong H. INDIVIDUAL ARTICLE: Real-World Patient Cases Using Botanical Serum-Containing Corrective Gel as an Adjunct to Aesthetic Facial Laser or Microneedling Radiofrequency (MRF) Treatment. Journal of Drugs in Dermatology : Jdd. 23: SF400676s3-SF400676s. PMID 38443134 DOI: 10.36849/jdd.SF400676  0.12
2024 Burgess C, Gold M, Farris PK, Hazan A, Raymond I. A Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical. Journal of Drugs in Dermatology : Jdd. 23: 160-167. PMID 38443131 DOI: 10.36849/jdd.8138  0.12
2024 Harper JC, Kircik LH, Gold M, Hebert AA, Sugarman JL, Green L, Gold LS, Baldwin H, Guenin E, DelRosso JQ. Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel. Journal of Drugs in Dermatology : Jdd. 23: 125-131. PMID 38443130 DOI: 10.36849/jdd.7907  0.12
2024 Gedeon JY, Pineda-Farias JB, Gold MS. In-Vivo Calcium Imaging of Sensory Neurons in the Rat Trigeminal Ganglion. Journal of Visualized Experiments : Jove. PMID 38407223 DOI: 10.3791/65978  0.12
2013 Davis A, Gold MS. Foreword Eating Disorders, Addictions and Substance Use Disorders: Research, Clinical and Treatment Perspectives. vii-viii. DOI: 10.1007/978-3-642-45378-6  0.12
1982 Gold MS, Fox CF. “Antianxiety and opiates” Behavioral and Brain Sciences. 5: 486-487. DOI: 10.1017/S0140525X00013108  0.12
2020 Chebar Lozinsky A, Loke P, Orsini F, O'Sullivan M, L Prescott S, Gold MS, Quinn P, DunnGalvin A, Lk Tang M. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study). Bmj Open. 10: e035871. PMID 32912942 DOI: 10.1136/bmjopen-2019-035871  0.12
2012 Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I. Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatric Disease and Treatment. 8: 85-93. PMID 22347799 DOI: 10.2147/NDT.S12518  0.119
1985 Dackis CA, Gold MS, Davies RK, Sweeney DR. Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis. International Journal of Psychiatry in Medicine. 15: 125-35. PMID 3902694 DOI: 10.2190/GXPA-98AK-4RR4-HD9B  0.119
1987 Cocores JA, Patel MD, Gold MS, Pottash AC. Cocaine abuse, attention deficit disorder, and bipolar disorder. The Journal of Nervous and Mental Disease. 175: 431-2. PMID 3598571 DOI: 10.1097/00005053-198707000-00007  0.118
2004 Kleiner KD, Gold MS, Frost-Pineda K, Lenz-Brunsman B, Perri MG, Jacobs WS. Body mass index and alcohol use. Journal of Addictive Diseases. 23: 105-18. PMID 15256347 DOI: 10.1300/J069V23N03_08  0.118
1989 Miller NS, Gold MS, Belkin BM, Klahr AL. Family history and diagnosis of alcohol dependence in cocaine dependence. Psychiatry Research. 29: 113-21. PMID 2798591 DOI: 10.1016/0165-1781(89)90026-7  0.118
2011 Edge PJ, Gold MS. Drug withdrawal and Hyperphagia: Lessons from Tobacco and other drugs Current Pharmaceutical Design. 17: 1173-1179. PMID 21492091  0.118
1992 Jonas JM, Gold MS. The Pharmacologic Treatment of Alcohol and Cocaine Abuse Psychiatric Clinics of North America. 15: 179-190. DOI: 10.1016/S0193-953X(18)30264-8  0.117
1990 Miller NS, Gold MS, Belkin BM, Klahr AL. The diagnosis of alcohol and cannabis dependence in cocaine dependents and alcohol dependence in their families. British Journal of Addiction. 84: 1491-8. PMID 2611432 DOI: 10.1111/J.1360-0443.1989.TB03931.X  0.116
1982 Gold MS, Dackis CA, Pottash AL, Sternbach HH, Annitto WJ, Martin D, Dackis MP. Naltrexone, opiate addiction, and endorphins. Medicinal Research Reviews. 2: 211-46. PMID 6289026 DOI: 10.1002/MED.2610020302  0.116
1978 Gold MS, Redmond DE, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet (London, England). 2: 599-602. PMID 80526 DOI: 10.1016/S0140-6736(78)92823-4  0.116
2013 Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, et al. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 176-88. PMID 23043900 DOI: 10.1016/J.Jalz.2012.03.002  0.116
2005 Bowman S, Gold M, Nasir A, Vamvakias G. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology : Jdd. 4: 611-618. PMID 16167420  0.116
2014 Blum K, Oscar-Berman M, Badgaiyan RD, Palomo T, Gold MS. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Medical Hypotheses. 82: 606-14. PMID 24636783 DOI: 10.1016/j.mehy.2014.02.019  0.116
2004 Hodgkins CC, Cahill KS, Seraphine AE, Frost-Pineda K, Gold MS. Adolescent drug addiction treatment and weight gain. Journal of Addictive Diseases. 23: 55-65. PMID 15256344 DOI: 10.1300/J069V23N03_05  0.115
2018 Alexis A, Del Rosso JQ, Desai SR, Downie JB, Draelos ZD, Feser C, Forconi R, Fowler JF, Gold M, Kaufman-Janette J, Lain E, Lee M, Ling M, Shamban AT, Werschler WP, et al. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris. The Journal of Clinical and Aesthetic Dermatology. 11: 25-35. PMID 30588271  0.115
1987 Dackis CA, Gold MS, Sweeney DR, Byron JP, Climko R. Single-dose bromocriptine reverses cocaine craving Psychiatry Research. 20: 261-264. PMID 3602212 DOI: 10.1016/0165-1781(87)90086-2  0.115
1987 Dackis CA, Gold MS, Pottash AL. Central stimulant abuse: neurochemistry and pharmacotherapy. Advances in Alcohol & Substance Abuse. 6: 7-21. PMID 2886014 DOI: 10.1300/J251V06N02_02  0.115
2008 Liu J, Pan H, Gold MS, Derendorf H, Bruijnzeel AW. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats. Neuropharmacology. 55: 812-8. PMID 18634811 DOI: 10.1016/J.Neuropharm.2008.06.034  0.114
2013 Cottler LB, Ajinkya S, Merlo LJ, Nixon SJ, Ben Abdallah A, Gold MS. Lifetime psychiatric and substance use disorders among impaired physicians in a physicians health program: comparison to a general treatment population: psychopathology of impaired physicians. Journal of Addiction Medicine. 7: 108-12. PMID 23412081 DOI: 10.1097/Adm.0B013E31827Fadc9  0.114
2008 Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. The American Journal of Drug and Alcohol Abuse. 34: 347-53. PMID 18428077 DOI: 10.1080/00952990802010892  0.114
2020 Oesterle TS, Kolla BP, Rummans TA, Gold MS. Medication-assisted therapies for opioid use disorders in patients with chronic pain. Journal of the Neurological Sciences. 411: 116728. PMID 32092625 DOI: 10.1016/j.jns.2020.116728  0.113
2017 Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, Thanos PK, Ferris CF, Kulkarni P, Giordano J, Baron D, Gold MS. Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. Plos One. 12: e0174774. PMID 28445527 DOI: 10.1371/Journal.Pone.0174774  0.113
2021 Avena NM, Simkus J, Lewandowski A, Gold MS, Potenza MN. Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions. Frontiers in Psychiatry. 12: 653674. PMID 33935838 DOI: 10.3389/fpsyt.2021.653674  0.113
1985 Estroff TW, Dackis CA, Gold MS, Pottash AL. Drug abuse and bipolar disorders. International Journal of Psychiatry in Medicine. 15: 37-40. PMID 4055245 DOI: 10.2190/6D4M-J23X-L21C-TP21  0.113
2012 Avena NM, Gold JA, Kroll C, Gold MS. Further developments in the neurobiology of food and addiction: update on the state of the science. Nutrition (Burbank, Los Angeles County, Calif.). 28: 341-3. PMID 22305533 DOI: 10.1016/J.Nut.2011.11.002  0.112
1985 Annitto WJ, Gold MS. The Fair Oaks Hospital cocaine treatment program. Journal of Substance Abuse Treatment. 1: 223-6. PMID 6536766 DOI: 10.1016/0740-5472(84)90025-4  0.112
2007 Warren MW, Zheng W, Kobeissy FH, Cheng Liu M, Hayes RL, Gold MS, Larner SF, Wang KK. Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 479-89. PMID 16882358 DOI: 10.1017/S1461145706007061  0.112
2021 Blum K, Gold MS, Llanos-Gomez L, Jalali R, Thanos PK, Bowirrat A, Downs WB, Bagchi D, Braverman ER, Baron D, Roy AK, Badgaiyan RD. Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction? International Journal of Environmental Research and Public Health. 18. PMID 34574696 DOI: 10.3390/ijerph18189774  0.112
2010 Bowirrat A, Chen TJ, Blum K, Madigan M, Bailey JA, Chuan Chen AL, Downs BW, Braverman ER, Radi S, Waite RL, Kerner M, Giordano J, Morse S, Oscar-Berman M, Gold M. Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Current Neuropharmacology. 8: 335-58. PMID 21629442 DOI: 10.2174/157015910793358123  0.112
2019 Srivastava AB, Kobiessy FH, Gold MS. Qualitative vs. Quantitative Methods in Psychiatric Research: Updated. Methods in Molecular Biology (Clifton, N.J.). 2011: 23-37. PMID 31273691 DOI: 10.1007/978-1-4939-9554-7_2  0.112
2010 Liu Y, von Deneen KM, Kobeissy FH, Gold MS. Food addiction and obesity: evidence from bench to bedside. Journal of Psychoactive Drugs. 42: 133-45. PMID 20648909 DOI: 10.1080/02791072.2010.10400686  0.112
2006 McCusker RR, Fuehrlein B, Goldberger BA, Gold MS, Cone EJ. Caffeine content of decaffeinated coffee Journal of Analytical Toxicology. 30: 611-613. PMID 17132260 DOI: 10.1093/Jat/30.8.611  0.112
2011 Gold MS. From bedside to bench and back again: A 30-year saga Physiology and Behavior. 104: 157-161. PMID 21530563 DOI: 10.1016/j.physbeh.2011.04.027  0.112
2003 Shapira NA, Lessig MC, Goldsmith TD, Szabo ST, Lazoritz M, Gold MS, Stein DJ. Problematic internet use: proposed classification and diagnostic criteria. Depression and Anxiety. 17: 207-16. PMID 12820176 DOI: 10.1002/Da.10094  0.112
1989 Miller N, Gold M, Belkin B. Clinical Laboratory Testing in Drug Abuse and Addiction Annals of Clinical Psychiatry. 1: 227-236. DOI: 10.3109/10401238909149987  0.111
1990 Miller NS, Klahr AL, Gold MS, Sweeney K, Cocores JA, Sweeney DR. Cannabis diagnosis of patients receiving treatment for cocaine dependence. Journal of Substance Abuse. 2: 107-11. PMID 2136098 DOI: 10.1016/S0899-3289(05)80049-5  0.111
2015 Razafsha M, Khaku A, Azari H, Alawieh A, Behforuzi H, Fadlallah B, Kobeissy FH, Wang KK, Gold MS. Biomarker identification in psychiatric disorders: from neuroscience to clinical practice. Journal of Psychiatric Practice. 21: 37-48. PMID 25603450 DOI: 10.1097/01.Pra.0000460620.87557.02  0.111
2014 Orsini CA, Ginton G, Shimp KG, Avena NM, Gold MS, Setlow B. Food consumption and weight gain after cessation of chronic amphetamine administration. Appetite. 78: 76-80. PMID 24667154 DOI: 10.1016/J.Appet.2014.03.013  0.111
1985 Washton AM, Gold MS, Pottash AC. Upper-income cocaine abusers. Advances in Alcohol & Substance Abuse. 4: 51-7. PMID 6524506 DOI: 10.1300/J251V04N02_05  0.11
2021 Blum K, Khalsa J, Cadet JL, Baron D, Bowirrat A, Boyett B, Lott L, Brewer R, Gondré-Lewis M, Bunt G, Kazmi S, Gold MS. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Frontiers in Psychiatry. 12: 623403. PMID 33868044 DOI: 10.3389/fpsyt.2021.623403  0.11
2015 Blum K, Febo M, Smith DE, Roy AK, Demetrovics Z, Cronjé FJ, Femino J, Agan G, Fratantonio JL, Pandey SC, Badgaiyan RD, Gold MS. Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation. Journal of Child and Adolescent Psychopharmacology. 25: 286-92. PMID 25919973 DOI: 10.1089/Cap.2014.0146  0.11
2009 DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: Physicians' Health Programs. Journal of Substance Abuse Treatment. 36: 159-71. PMID 19161896 DOI: 10.1016/J.Jsat.2008.01.004  0.11
2015 Zhang Y, Wang J, Zhang G, Zhu Q, Cai W, Tian J, Zhang YE, Miller JL, Wen X, Ding M, Gold MS, Liu Y. The neurobiological drive for overeating implicated in Prader-Willi syndrome. Brain Research. PMID 25998539 DOI: 10.1016/J.Brainres.2015.05.008  0.11
2009 DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the Standard for Recovery: Physicians' Health Programs Journal of Medical Regulation. 95: 10-25. DOI: 10.30770/2572-1852-95.4.10  0.11
2007 Warren MW, Larner SF, Kobeissy FH, Brezing CA, Jeung JA, Hayes RL, Gold MS, Wang KK. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathologica. 114: 277-86. PMID 17647000 DOI: 10.1007/S00401-007-0259-9  0.109
1985 Dackis CA, Estroff TW, Sweeney DR, Pottash AL, Gold MS. Specificity of the TRH test for major depression in patients with serious cocaine abuse. The American Journal of Psychiatry. 142: 1097-9. PMID 3927753 DOI: 10.1176/AJP.142.9.1097  0.109
2005 Coleman JJ, Bensinger PB, Gold MS, Smith DE, Bianchi RP, DuPont RL. Can drug design inhibit abuse? Journal of Psychoactive Drugs. 37: 343-62. PMID 16480162 DOI: 10.1080/02791072.2005.10399808  0.109
2019 Duszynski KM, Pratt NL, Lynch JW, Braunack-Mayer A, Taylor LK, Berry JG, Xafis V, Buttery J, Gold MS. Process trumps potential public good: better vaccine safety through linked cross-jurisdictional immunisation data in Australia. Australian and New Zealand Journal of Public Health. PMID 31535432 DOI: 10.1111/1753-6405.12929  0.109
1992 Miller NS, Gold MS, Mahler JC. Violent behaviors associated with cocaine use: possible pharmacological mechanisms. The International Journal of the Addictions. 26: 1077-88. PMID 1683859 DOI: 10.3109/10826089109058942  0.108
2006 Bruijnzeel AW, Lewis B, Bajpai LK, Morey TE, Dennis DM, Gold M. Severe deficit in brain reward function associated with fentanyl withdrawal in rats. Biological Psychiatry. 59: 477-80. PMID 16169528 DOI: 10.1016/j.biopsych.2005.07.020  0.108
1993 Miller NS, Gold MS. A Hypothesis for a Common Neurochemical Basis for Alcohol and Drug Disorders Psychiatric Clinics of North America. 16: 105-117. DOI: 10.1016/S0193-953X(18)30194-1  0.108
2016 Hongcharu W, Gold M. Expanding the Clinical Application of Fractional Radiofrequency Treatment: Findings on Rhytides, Hyperpigmentation, Rosacea, and Acne Redness. Journal of Drugs in Dermatology : Jdd. 14: 1298-304. PMID 26580880  0.108
2014 Cottler LB, Ajinkya S, Goldberger BA, Ghani MA, Martin DM, Hu H, Gold MS. Prevalence of drug and alcohol use in urban Afghanistan: epidemiological data from the Afghanistan National Urban Drug Use Study (ANUDUS). The Lancet. Global Health. 2: e592-600. PMID 25304635 DOI: 10.1016/S2214-109X(14)70290-6  0.108
2021 Blum K, Gold MS, Cadet JL, Baron D, Bowirrat A, Thanos PK, Brewer R, Badgaiyan RD, Gondré–Lewis MC. Dopaminylation in Psychostimulant use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression Current Psychopharmacology. 9. DOI: 10.2174/2211556009666210108112737  0.108
2011 Johnson RJ, Gold MS, Johnson DR, Ishimoto T, Lanaspa MA, Zahniser NR, Avena NM. Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption? Postgraduate Medicine. 123: 39-49. PMID 21904085 DOI: 10.3810/Pgm.2011.09.2458  0.108
1986 Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neuroscience and Biobehavioral Reviews. 9: 469-77. PMID 2999657 DOI: 10.1016/0149-7634(85)90022-3  0.108
1995 Miller NS, Gold MS. The Role of the Psychiatrist in Treatment of Relapse in Addictive Disorders Psychiatric Annals. 25: 673-678. DOI: 10.3928/0048-5713-19951101-09  0.107
2011 Gold J, Gold MS. Exercise for the overweight and obese. Current Pharmaceutical Design. 17: 1193-7. PMID 21492089  0.107
1988 Cocores JA, Miller NS, Pottash AC, Gold MS. Sexual dysfunction in abusers of cocaine and alcohol. The American Journal of Drug and Alcohol Abuse. 14: 169-73. PMID 2902781 DOI: 10.3109/00952999809001544  0.107
1986 Semlitz L, Gold MS. Adolescent Drug Abuse: Diagnosis, Treatment, and Prevention Psychiatric Clinics of North America. 9: 455-473. DOI: 10.1016/S0193-953X(18)30606-3  0.107
1987 Lehrer M, Gold MS. Laboratory diagnosis of cocaine: intoxication and withdrawal. Advances in Alcohol & Substance Abuse. 6: 123-41. PMID 3604787 DOI: 10.1300/J251V06N02_09  0.107
1985 Dackis CA, Gold MS. Bromocriptine as treatment of cocaine abuse. Lancet (London, England). 1: 1151-2. PMID 2860349 DOI: 10.1016/S0140-6736(85)92448-1  0.107
1987 Washton AM, Gold MS. Recent trends in cocaine abuse: a view from the National Hotline, "800-COCAINE". Advances in Alcohol & Substance Abuse. 6: 31-47. PMID 3496737 DOI: 10.1300/J251V06N02_04  0.107
2015 Blum K, Thanos PK, Badgaiyan RD, Febo M, Oscar-Berman M, Fratantonio J, Demotrovics Z, Gold MS. Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? Expert Opinion On Biological Therapy. 15: 973-85. PMID 25974314 DOI: 10.1517/14712598.2015.1045871  0.107
2021 Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug. American Journal of Clinical Dermatology. PMID 34674160 DOI: 10.1007/s40257-021-00650-3  0.106
2007 Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, Leyden J, Wortzman M. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. Journal of Drugs in Dermatology : Jdd. 6: 607-15. PMID 17668526  0.106
1988 Extein IL, Gold MS. The Treatment of Cocaine Addicts: Bromocriptine or Desipramine Psychiatric Annals. 18: 535-537. DOI: 10.3928/0048-5713-19880901-11  0.106
1986 Estroff TW, Gold MS. Psychiatric Presentations of Marijuana Abuse Psychiatric Annals. 16: 221-224. DOI: 10.3928/0048-5713-19860401-08  0.105
2007 Merlo LJ, Gold MS. Patients With Substance Abuse Problems: Effective Identification, Diagnosis, and Treatment Jama. 298: 807-812. PMID 22600381 DOI: 10.1001/Jama.298.7.808  0.105
1992 Miller NS, Gold MS. The Psychiatrist's Role in Integrating Pharmacological and Nonpharmacological Treatments for Addictive Disorders Psychiatric Annals. 22: 436-440. DOI: 10.3928/0048-5713-19920801-10  0.105
2021 Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. The American Journal of Psychiatry. appiajp202121030320. PMID 34875873 DOI: 10.1176/appi.ajp.2021.21030320  0.105
2017 Shiwarski DJ, Tipton A, Giraldo MD, Schmidt BF, Gold MS, Pradhan AA, Puthenveedu MA. A PTEN-regulated checkpoint regulates surface delivery of delta opioid receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28264976 DOI: 10.1523/Jneurosci.2923-16.2017  0.105
2011 Mao J, Gold MS, Backonja MM. Combination drug therapy for chronic pain: a call for more clinical studies. The Journal of Pain : Official Journal of the American Pain Society. 12: 157-66. PMID 20851058 DOI: 10.1016/j.jpain.2010.07.006  0.104
2014 Shriner R, Gold M. Food addiction: an evolving nonlinear science. Nutrients. 6: 5370-91. PMID 25421535 DOI: 10.3390/nu6115370  0.104
1995 DuPont RL, Gold MS. Withdrawal and Reward: Implications for Detoxification and Relapse Prevention Psychiatric Annals. 25: 663-668. DOI: 10.3928/0048-5713-19951101-07  0.104
2010 Blum K, Chen TJ, Chen AL, Madigan M, Downs BW, Waite RL, Braverman ER, Kerner M, Bowirrat A, Giordano J, Henshaw H, Gold MS. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). Medical Hypotheses. 74: 513-20. PMID 19914781 DOI: 10.1016/j.mehy.2009.10.008  0.104
1980 Gold MS, Pottash AL, Finn LB, Kleber HD, Extein I. Serum prolactin and opiate withdrawal. Psychiatry Research. 2: 205-10. PMID 6932063 DOI: 10.1016/0165-1781(80)90078-5  0.103
2006 Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. Journal of Addictive Diseases. 24: 95-100. PMID 16186086 DOI: 10.1300/J069v24n03_08  0.103
2022 Gupta A, Bowirrat A, Gomez LL, Baron D, Elman I, Giordano J, Jalali R, Badgaiyan RD, Modestino EJ, Gold MS, Braverman ER, Bajaj A, Blum K. Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. International Journal of Environmental Research and Public Health. 19. PMID 35010811 DOI: 10.3390/ijerph19010552  0.103
2013 Morimoto BH, Fox AW, Stewart AJ, Gold M. Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases. Expert Review of Clinical Pharmacology. 6: 483-502. PMID 23971871 DOI: 10.1586/17512433.2013.827403  0.103
1983 Gold MS, Rea WS. The Role of Endorphins in Opiate Addiction, Opiate Withdrawal, and Recovery Psychiatric Clinics of North America. 6: 489-520. DOI: 10.1016/S0193-953X(18)30820-7  0.102
2023 Lloyd M, Loke P, Ashley S, Lozinsky AC, Orsini F, O'Sullivan M, Gold M, Quinn P, Metcalfe J, Tang ML. Interaction between baseline participant factors and treatment effects following peanut oral immunotherapy. The Journal of Allergy and Clinical Immunology. in Practice. PMID 38154554 DOI: 10.1016/j.jaip.2023.12.028  0.102
1986 Jonas JM, Gold MS. Cocaine abuse and eating disorders. Lancet (London, England). 1: 390-1. PMID 2868333 DOI: 10.1016/S0140-6736(86)92360-3  0.102
2009 Gold MS, Kobeissy FH, Wang KK, Merlo LJ, Bruijnzeel AW, Krasnova IN, Cadet JL. Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biological Psychiatry. 66: 118-27. PMID 19345341 DOI: 10.1016/J.Biopsych.2009.02.021  0.102
2011 Zhang Y, Tian J, Yuan K, Liu P, Zhuo L, Qin W, Zhao L, Liu J, von Deneen KM, Klahr NJ, Gold MS, Liu Y. Distinct resting-state brain activities in heroin-dependent individuals. Brain Research. 1402: 46-53. PMID 21669407 DOI: 10.1016/J.Brainres.2011.05.054  0.101
2010 Merlo LJ, Blumenthal KG, Campbell K, Omli M, Gold MS. Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders Addictive Disorders in Medical Populations. 503-523. DOI: 10.1002/9780470710449.ch33  0.101
2008 Merlo LJ, Goldberger BA, Kolodner D, Fitzgerald K, Gold MS. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. Journal of Addictive Diseases. 27: 67-76. PMID 18956530 DOI: 10.1080/10550880802122661  0.101
2017 Blum K, Thanos PK, Wang GJ, Febo M, Demetrovics Z, Modestino EJ, Braverman ER, Baron D, Badgaiyan RD, Gold MS. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. Current Pharmaceutical Design. PMID 28831923 DOI: 10.2174/1381612823666170823101713  0.101
2014 Blum K, Oscar-Berman M, Badgaiyan R, Braverman ER, Gold MS. Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function. Psychology (Irvine, Calif.). 5: 282-288. PMID 25009759 DOI: 10.4236/psych.2014.54038  0.101
2008 Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, ... ... Gold MS, et al. Methamphetamine causes microglial activation in the brains of human abusers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 5756-61. PMID 18509037 DOI: 10.1523/JNEUROSCI.1179-08.2008  0.101
2013 Wang Y, Zhu J, Chen L, Liu Y, Li Q, Yang W, Li W, Zhao L, Gold MS, Sun J, Wang W. The effect of nucleus accumbens lesions on appetite, sexual function, and nicotine dependence in recovering heroin addicts Translational Neuroscience. 4: 419-428. DOI: 10.2478/S13380-013-0146-X  0.101
1986 Dackis CA, Gold MS. Pharmacological approaches to cocaine addiction. Journal of Substance Abuse Treatment. 2: 139-45. PMID 3912517 DOI: 10.1016/0740-5472(85)90043-1  0.101
2016 Colon-Perez LM, Tran K, Thompson K, Pace MC, Blum K, Goldberger BA, Gold MS, Bruijnzeel AW, Setlow B, Febo M. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26997298 DOI: 10.1038/Npp.2016.40  0.101
2004 Szabo ST, Gold MS, Goldberger BA, Blier P. Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biological Psychiatry. 55: 934-9. PMID 15110737 DOI: 10.1016/J.Biopsych.2003.12.013  0.101
2020 Blum K, Cadet JL, Baron D, Badgaiyan RD, Brewer R, Modestino EJ, Gold MS. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? Substance Use & Misuse. 1-5. PMID 32957797 DOI: 10.1080/10826084.2020.1817086  0.101
2007 Gold MS, Hammond CJ. Pathological Gambling Focused CBT: The Application of Addiction-Based Treatments Provides Another Tool in the Therapist's Toolbox Psyccritiques. 52. DOI: 10.1037/A0008532  0.101
1981 Pottash AL, Black HR, Gold MS. Psychiatric complications of antihypertensive medications. The Journal of Nervous and Mental Disease. 169: 430-8. PMID 7241108 DOI: 10.1097/00005053-198107000-00004  0.101
1993 Gold MS. Opiate Addiction and the Locus Coeruleus: The Clinical Utility of Clonidine, Naltrexone, Methadone, and Buprenorphine Psychiatric Clinics of North America. 16: 61-73. DOI: 10.1016/S0193-953X(18)30190-4  0.101
1989 Extein IL, Gross DA, Gold MS. Bromocriptine treatment of cocaine withdrawal symptoms American Journal of Psychiatry. 146: 403. PMID 2645797 DOI: 10.1176/ajp.146.3.403a  0.101
2022 Mishra P, Patil A, Sinclair R, Gold M, Rudnicka L, Grabbe S, Goldust M. Treatment of Alopecia in Children. Journal of Drugs in Dermatology : Jdd. 21: 49-53. PMID 35005859 DOI: 10.36849/JDD.2022.6096  0.101
2018 Snyder LM, Chiang MC, Loeza-Alcocer E, Omori Y, Hachisuka J, Sheahan TD, Gale JR, Adelman PC, Sypek EI, Fulton SA, Friedman RL, Wright MC, Duque MG, Lee YS, Hu Z, ... ... Gold MS, et al. Kappa Opioid Receptor Distribution and Function in Primary Afferents. Neuron. 99: 1274-1288.e6. PMID 30236284 DOI: 10.1016/J.Neuron.2018.08.044  0.1
2007 Hodgkins C, Frost-Pineda K, Gold MS. Weight gain during substance abuse treatment: The dual problem of addiction and overeating in an adolescent population Journal of Addictive Diseases. 26: 41-50. PMID 19283973 DOI: 10.1300/J069V26S01_05  0.1
1995 Dupre D, Miller N, Gold M, Rospenda K. Initiation and Progression of Alcohol, Marijuana, and Cocaine Use Among Adolescent Abusers The American Journal On Addictions. 4: 43-48. DOI: 10.1111/J.1521-0391.1995.TB00257.X  0.1
1987 Estroff TW, Extein IL, Malaspina D, Gold MS. Hepatitis in 101 consecutive suburban cocaine and opiate users. International Journal of Psychiatry in Medicine. 16: 237-42. PMID 3804585 DOI: 10.2190/FPFB-H05B-4V9V-TLCT  0.1
2012 Archer T, Oscar-Berman M, Blum K, Gold M. Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry. Journal of Genetic Syndromes & Gene Therapy. 3: 1000115. PMID 23264884 DOI: 10.4172/2157-7412.1000115  0.1
2004 Tullis LM, Dupont R, Frost-Pineda K, Gold MS. Marijuana and tobacco: a major connection? Journal of Addictive Diseases. 22: 51-62. PMID 14621344 DOI: 10.1300/J069v22n03_05  0.1
2017 Kalilani L, Lu C, Pierre-Louis B, Gold M. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. Epilepsy & Behavior : E&B. 72: 51-57. PMID 28575767 DOI: 10.1016/j.yebeh.2017.04.017  0.1
2013 Peniston JH, Gold MS, Wieman MS, Alwine LK. Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac. Therapeutics and Clinical Risk Management. 9: 153-9. PMID 23620668 DOI: 10.2147/TCRM.S41931  0.099
2012 Kobeissy F, Alawieh A, Mondello S, Boustany RM, Gold MS. Biomarkers in psychiatry: how close are we? Frontiers in Psychiatry. 3: 114. PMID 23316174 DOI: 10.3389/Fpsyt.2012.00114  0.099
2019 Blum K, Pappas TC, Clifton B, Baron D, Madigan MA, Lott L, Moran M, Clifton C, Worrich S, Clarke E, Boyett B, Bowirrat A, Gold MS. Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action Current Psychopharmacology. 8: 99-112. DOI: 10.2174/2211556008666190827150018  0.099
2014 Avena NM, Bocarsly ME, Murray S, Gold MS. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats. Experimental and Clinical Psychopharmacology. 22: 460-7. PMID 25069013 DOI: 10.1037/A0037223  0.099
2017 Ameratunga R, Gillis D, Gold M, Linneberg A, Elwood JM. Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). The Journal of Allergy and Clinical Immunology. in Practice. 5: 1551-1555.e1. PMID 28888842 DOI: 10.1016/j.jaip.2017.06.033  0.099
2013 Greenberg BD, Carrillo MC, Ryan JM, Gold M, Gallagher K, Grundman M, Berman RM, Ashwood T, Siemers ER. Improving Alzheimer's disease phase II clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 39-49. PMID 23164548 DOI: 10.1016/J.Jalz.2012.02.002  0.099
2009 Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). Postgraduate Medicine. 121: 176-96. PMID 19940429 DOI: 10.3810/Pgm.2009.11.2087  0.099
1990 Miller N, Gold M, Mahler J. A Study of Violent Behaviors Associated with Cocaine Use: Theoretical and Pharmacological Implications Annals of Clinical Psychiatry. 2: 67-71. DOI: 10.3109/10401239009150009  0.099
1989 Miller N, Gold M, Millman R. The Prevalence of Alcohol Dependence in Cocaine Dependence in an Inpatient Population Annals of Clinical Psychiatry. 1: 93-97. DOI: 10.3109/10401238909149963  0.098
2016 Wiss DA, Criscitelli K, Gold M, Avena N. Preclinical evidence for the addiction potential of highly palatable foods: Current developments related to maternal influence. Appetite. 115: 19-27. PMID 27989563 DOI: 10.1016/j.appet.2016.12.019  0.098
1984 Washton AM, Gold MS. Chronic Cocaine Abuse: Evidence for Adverse Effects on Health and Functioning Psychiatric Annals. 14: 733-743. DOI: 10.3928/0048-5713-19841001-09  0.098
2010 Cocores JA, Graham NA, Gold MS. Addictive Disorders in Nutritional Diseases-From an Addictions Viewpoint Addictive Disorders in Medical Populations. 287-302. DOI: 10.1002/9780470710449.ch19  0.098
1992 Gold MS, Miller NS. Seeking Drugs/Alcohol and Avoiding Withdrawal: The Neuroanatomy of Drive States and Withdrawal Psychiatric Annals. 22: 430-435. DOI: 10.3928/0048-5713-19920801-09  0.097
1992 Newman MM, Gold MS. Preliminary findings of patterns of substance abuse in eating disorder patients. The American Journal of Drug and Alcohol Abuse. 18: 207-11. PMID 1562016 DOI: 10.3109/00952999208992833  0.097
2006 Rylkova D, Bruijnzeel AW, Gold MS. Anabolic Steroid Abuse Journal of Addictive Diseases. 25: 33-45. DOI: 10.1300/J069v25S01_04  0.097
2019 Nestor MS, Berman B, Goldberg D, Cognetta AB, Gold M, Roth W, Cockerell CJ, Glick B. Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids. The Journal of Clinical and Aesthetic Dermatology. 12: 12-18. PMID 30881578  0.097
2015 McLaughlin T, Blum K, Oscar-Berman M, Febo M, Demetrovics Z, Agan G, Fratantonio J, Gold MS. Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis. Journal of Reward Deficiency Syndrome. 1: 24-35. PMID 26065033 DOI: 10.17756/jrds.2015-006  0.097
2021 Blum K, Modestino EJ, Baron D, Brewer R, Thanos P, Elman I, Badgaiyan RD, Downs BW, Bagchi D, McLaughlin T, Bowirrat A, Roy AK, Gold MS. Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) Activation of Neuro-immunological Function in the Face of a Viral Pandemic. Current Psychopharmacology. 10: 86-97. PMID 34466374 DOI: 10.2174/2211556009999210104221215  0.097
2007 Bruijnzeel AW, Marcinkiewcz C, Isaac S, Booth MM, Dennis DM, Gold MS. The effects of buprenorphine on fentanyl withdrawal in rats. Psychopharmacology. 191: 931-41. PMID 17211652 DOI: 10.1007/S00213-006-0670-2  0.096
2008 Merlo LJ, Carnes PJ, Gold MS. Response to "Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects". The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 247-8; author reply . PMID 18464004 DOI: 10.1080/10550490802019857  0.096
2013 Razafsha M, Behforuzi H, Harati H, Wafai RA, Khaku A, Mondello S, Gold MS, Kobeissy FH. An updated overview of animal models in neuropsychiatry. Neuroscience. 240: 204-18. PMID 23473749 DOI: 10.1016/J.Neuroscience.2013.02.045  0.096
2013 Yarnell S, Oscar-Berman M, Avena N, Blum K, Gold M. Pharmacotherapies for Overeating and Obesity. Journal of Genetic Syndromes & Gene Therapy. 4: 131. PMID 23826512 DOI: 10.4172/2157-7412.1000131  0.095
2012 Reisfield GM, Goldberger BA, Gold MS, DuPont RL. The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws. Journal of Analytical Toxicology. 36: 353-6. PMID 22582272 DOI: 10.1093/jat/bks037  0.095
2015 Blum K, Badgaiyan RD, Angres DH, Gold MS. Should We Embrace Vaccines for Treating Substance-Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)? Journal of Reward Deficiency Syndrome. 1: 3-5. PMID 26052554 DOI: 10.17756/jrds.2015-001  0.095
2009 Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl KS, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, et al. Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine. 27: 2282-8. PMID 19056451 DOI: 10.1016/j.vaccine.2008.11.036  0.095
2011 Xafis V, Thomson C, Braunack-Mayer AJ, Duszynski KM, Gold MS. Legal impediments to data linkage. Journal of Law and Medicine. 19: 300-15. PMID 22320005  0.095
2007 DuPont RL, Graham NA, Gold MS. Opioid treatment for chronic back pain and its association with addiction. Annals of Internal Medicine. 147: 349; author reply 34. PMID 17785497 DOI: 10.7326/0003-4819-147-5-200709040-00019  0.094
1993 Miller NS, Giannini AJ, Gold MS. Suicide risk associated with drug and alcohol addiction. Cleveland Clinic Journal of Medicine. 59: 535-8. PMID 1361427 DOI: 10.3949/CCJM.59.5.535  0.094
2003 Hodgkins CC, Jacobs WS, Gold MS. Weight Gain After Adolescent Drug Addiction Treatment and Supervised Abstinence Psychiatric Annals. 33: 112-116. DOI: 10.3928/0048-5713-20030201-07  0.094
1991 Miller NS, Mahler JC, Gold MS. Suicide risk associated with drug and alcohol dependence. Journal of Addictive Diseases. 10: 49-61. PMID 1932152 DOI: 10.1300/J069V10N03_06  0.094
1994 Miller NS, Gold MS. LSD and Ecstasy: Pharmacology, Phenomenology, and Treatment Psychiatric Annals. 24: 131-133. DOI: 10.3928/0048-5713-19940301-07  0.094
2011 Avena NM, Wang M, Gold MS. Implications of food addiction and drug use in obesity Psychiatric Annals. 41: 478-482. DOI: 10.3928/00485713-20110921-06  0.094
2010 Kobeissy FH, Braga CF, Graham NA, Gold MS. Pharmacological Therapeutics for Detoxification in Addictive Disorders Addictive Disorders in Medical Populations. 481-502. DOI: 10.1002/9780470710449.ch32  0.093
1991 Miller N, Mahler J, Belkin B, Gold M. Psychiatric Diagnosis in Alcohol and Drug Dependence Annals of Clinical Psychiatry. 3: 79-89. DOI: 10.3109/10401239109147972  0.093
2004 James GA, Gold MS, Liu Y. Interaction of satiety and reward response to food stimulation. Journal of Addictive Diseases. 23: 23-37. PMID 15256342 DOI: 10.1300/J069v23n03_03  0.093
1983 Extein I, Kirstein LS, Pottash AL, Gold MS. The dexamethasone suppression and thyrotropin-releasing hormone tests and response to treatment in unipolar depression. International Journal of Psychiatry in Medicine. 12: 267-74. PMID 6820012 DOI: 10.2190/A6LE-QVA9-1LL1-XV49  0.093
2009 Kim JS, Judson MA, Donnino R, Gold M, Cooper LT, Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. American Heart Journal. 157: 9-21. PMID 19081391 DOI: 10.1016/j.ahj.2008.09.009  0.093
2007 Graham NA, Frost-Pineda K, Gold MS. Tobacco and psychiatric dual disorders. Journal of Addictive Diseases. 26: 5-12. PMID 19283970 DOI: 10.1300/J069v26S01_02  0.092
1982 Dackis CA, Pottash AL, Annitto W, Gold MS. Persistence of urinary marijuana levels after supervised abstinence. The American Journal of Psychiatry. 139: 1196-8. PMID 6287871 DOI: 10.1176/AJP.139.9.1196  0.092
1996 Johnson C, Gold M, Gleaton T. Hallucinogen and other illicit drug uses increases in the USA Biological Psychiatry. 39: 628. DOI: 10.1016/0006-3223(96)84379-4  0.092
2007 Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A, Erlewyn-Lajeunesse M, Martin S, Mäkelä M, Nell P, Pool V, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 25: 5675-84. PMID 17448577 DOI: 10.1016/j.vaccine.2007.02.064  0.092
1984 Gold MS, Pottash AL, Stoll A, Martin DM, Finn LB, Extein I. Nortriptyline plasma levels and clinical response in patients with familial pure unipolar depression and blunted TRH tests. International Journal of Psychiatry in Medicine. 13: 215-20. PMID 6418677 DOI: 10.2190/CYMK-0Y5W-U22T-0TDG  0.092
2014 Gold MS, Blum K, Oscar-Berman M, Braverman ER. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgraduate Medicine. 126: 153-77. PMID 24393762 DOI: 10.3810/pgm.2014.01.2735  0.091
1979 Gold MS, Pottash AL, Sweeney DR, Kleber HD, Redmond DE. Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates. The American Journal of Psychiatry. 136: 982-3. PMID 453367 DOI: 10.1176/ajp.136.7.982  0.091
2010 Greer RA, Gold MS. Pharmacological Drug Effects on Brain and Behavior Principles of Addictions and the Law. 177-192. DOI: 10.1016/B978-0-12-496736-6.00012-8  0.091
2011 Baraf HSB, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: Pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials Drugs and Aging. 28: 27-40. PMID 21174485 DOI: 10.2165/11584880-000000000-00000  0.091
1989 Miller NS, Gold MS. The human sexual response and alcohol and drugs. Journal of Substance Abuse Treatment. 5: 171-7. PMID 3070052 DOI: 10.1016/0740-5472(88)90006-2  0.091
2011 Von Deneen KM, Wei Q, Peng L, Hao DM, Peng C, Xie H, Tian J, Gold MS, Liu Y. Randomized fMRI trial of the central effects of acute acupuncture on glucose levels and core body temperature in "overweight" males Medical Acupuncture. 23: 165-173. DOI: 10.1089/Acu.2011.0802  0.091
1996 GOLD MS. Addiction Psychiatry: Current Diagnosis and Treatment American Journal of Psychiatry. 153: 439-440. DOI: 10.1176/AJP.153.3.439  0.091
2006 Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. The Medical Journal of Australia. 185: 283-9. PMID 16948628  0.09
2012 von Deneen KM, Gold MS, Liu Y. Food addiction and cues in prader-willi syndrome. Journal of Addiction Medicine. 3: 19-25. PMID 21768997 DOI: 10.1097/ADM.0b013e31819a6e5f  0.09
2012 Peniston JH, Gold MS, Wieman MS, Alwine LK. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clinical Interventions in Aging. 7: 517-23. PMID 23204844 DOI: 10.2147/CIA.S35416  0.09
1991 Miller NS, Gold MS. Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. The American Journal of Drug and Alcohol Abuse. 17: 27-37. PMID 1674837 DOI: 10.3109/00952999108992807  0.09
2005 Gold MS, Frost-Pineda K. Substance Abuse and Psychiatric Dual Disorders Journal of Dual Diagnosis. 1: 15-36. DOI: 10.1300/J374v01n01_03  0.09
1994 Gold MS. Neurobiology of addiction and recovery: the brain, the drive for the drug, and the 12-step fellowship. Journal of Substance Abuse Treatment. 11: 93-7. PMID 8040922 DOI: 10.1016/0740-5472(94)90022-1  0.09
2013 Herkov MJ, Gold MS. Etiology and Prevention of Stimulants (Including Cocaine, Amphetamines and Misuse of Prescription Stimulants) Interventions For Addiction. 815-822. DOI: 10.1016/B978-0-12-398338-1.00082-8  0.09
2006 Bruijnzeel AW, Zislis G, Wilson C, Gold MS. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 955-63. PMID 16943772 DOI: 10.1038/sj.npp.1301192  0.09
1981 Gold MS, Pottash AL, Extein I, Finn LB, Kleber HD. Clonidine in opiate withdrawal Current Psychiatric Therapies. 20: 285-291. PMID 7326972  0.09
1981 Gold MS, Pottash AL, Extein I, Kleber HD. Clonidine and opiate withdrawal. Lancet (London, England). 2: 1078-9. PMID 6107698 DOI: 10.1016/S0140-6736(80)92295-3  0.09
1978 Gold MS, Redmond DE, Kleber HD. Clonidine in opiate withdrawal. Lancet (London, England). 1: 929-30. PMID 76860 DOI: 10.1016/S0140-6736(78)90699-2  0.09
1988 Jonas JM, Gold MS. Naltrexone Treatment of Bulimia: Advances in Alcohol & Substance Abuse. 7: 29-37. DOI: 10.1300/J251V07N01_03  0.089
2006 Gold MS, Frost-Pineda K. Regarding "Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder". Biological Psychiatry. 60: 1166; author reply 1. PMID 16876131 DOI: 10.1016/j.biopsych.2006.04.016  0.089
2020 Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK. The therapeutic potential of exercise for neuropsychiatric diseases: A review. Journal of the Neurological Sciences. 412: 116763. PMID 32305746 DOI: 10.1016/J.Jns.2020.116763  0.089
1986 Gold MS, Washton AM, Dackis CA, Chatlos JC. New Treatments for Opiate and Cocaine Users: But What About Marijuana? Psychiatric Annals. 16: 206-214. DOI: 10.3928/0048-5713-19860401-06  0.089
2018 Gold M, Amatniek J, Carrillo MC, Cedarbaum JM, Hendrix JA, Miller BB, Robillard JM, Rice JJ, Soares H, Tome MB, Tarnanas I, Vargas G, Bain LJ, Czaja SJ. Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials. Alzheimer's & Dementia (New York, N. Y.). 4: 234-242. PMID 29955666 DOI: 10.1016/J.Trci.2018.04.003  0.089
2017 Gold M. Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough? Alzheimer's & Dementia (New York, N. Y.). 3: 402-409. PMID 29067346 DOI: 10.1016/j.trci.2017.04.005  0.089
2016 Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND. Chronic Methamphetamine Effects on Brain Structure and Function in Rats. Plos One. 11: e0155457. PMID 27275601 DOI: 10.1371/Journal.Pone.0155457  0.088
2017 Cashman P, Macartney K, Khandaker G, King C, Gold M, Durrheim DN. Participant-centred active surveillance of adverse events following immunisation: a narrative review. International Health. 9: 164-176. PMID 28582563 DOI: 10.1093/inthealth/ihx019  0.088
2004 Bekker AY, Basile J, Gold M, Riles T, Adelman M, Cuff G, Mathew JP, Goldberg JD. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. Journal of Neurosurgical Anesthesiology. 16: 126-35. PMID 15021281 DOI: 10.1097/00008506-200404000-00004  0.088
1982 Extein I, Pottash AL, Gold MS, Silver JM. Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement. Psychiatry Research. 6: 161-9. PMID 6806836 DOI: 10.1016/0165-1781(82)90004-X  0.088
2016 Zhang Y, Li Q, Wen X, Cai W, Li G, Tian J, Zhang YE, Liu J, Yuan K, Zhao J, Wang W, Zhou Z, Ding M, Gold MS, Liu Y, et al. Granger causality reveals a dominant role of memory circuit in chronic opioid dependence. Addiction Biology. PMID 26987308 DOI: 10.1111/Adb.12390  0.088
1988 Miller NS, Gold MS. Cocaine and Alcoholism: Distinct or Part of a Spectrum Psychiatric Annals. 18: 538-539. DOI: 10.3928/0048-5713-19880901-12  0.088
2021 Gold M. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older. Expert Review of Clinical Immunology. 17: 301-308. PMID 33616473 DOI: 10.1080/1744666X.2021.1894131  0.088
2012 Berry JG, Ryan P, Gold MS, Braunack-Mayer AJ, Duszynski KM. A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage. Journal of Medical Ethics. 38: 619-25. PMID 22518045 DOI: 10.1136/medethics-2011-100145  0.088
2021 Blum K, Bowirrat A, Gondre Lewis MC, Simpatico TA, Ceccanti M, Steinberg B, Modestino EJ, Thanos PK, Baron D, McLaughlin T, Brewer R, Badgaiyan RD, Ponce JV, Lott L, Gold MS. Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development. Current Psychopharmacology. 10. PMID 34707969 DOI: 10.2174/2211556010666210215155509  0.088
2022 Boccardi M, Handels R, Gold M, Grazia A, Lutz MW, Martin M, Nosheny R, Robillard JM, Weidner W, Alexandersson J, Thyrian JR, Winblad B, Barbarino P, Khachaturian AS, Teipel S. Clinical research in dementia: A perspective on implementing innovation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35325508 DOI: 10.1002/alz.12622  0.088
2020 El Hayek S, Allouch F, Razafsha M, Talih F, Gold MS, Wang KK, Kobeissy F. Traumatic brain injury and methamphetamine: A double-hit neurological insult. Journal of the Neurological Sciences. 411: 116711. PMID 32035311 DOI: 10.1016/J.Jns.2020.116711  0.088
1987 Roehrich H, Gold MS. Propranolol as adjunct to clonidine in opiate detoxification. The American Journal of Psychiatry. 144: 1099-100. PMID 3605433 DOI: 10.1176/ajp.144.8.1099b  0.088
2021 Rentz DM, Wessels AM, Annapragada AV, Berger AK, Edgar CJ, Gold M, Miller DS, Randolph C, Ryan JM, Wunderlich G, Zoschg MC, Trépel D, Knopman DS, Staffaroni AM, Bain LJ, et al. Building clinically relevant outcomes across the Alzheimer's disease spectrum. Alzheimer's & Dementia (New York, N. Y.). 7: e12181. PMID 34195350 DOI: 10.1002/trc2.12181  0.087
2014 Murray S, Tulloch A, Gold MS, Avena NM. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nature Reviews. Endocrinology. 10: 540-52. PMID 24958311 DOI: 10.1038/Nrendo.2014.91  0.087
2013 Krasnova IN, Chiflikyan M, Justinova Z, McCoy MT, Ladenheim B, Jayanthi S, Quintero C, Brannock C, Barnes C, Adair JE, Lehrmann E, Kobeissy FH, Gold MS, Becker KG, Goldberg SR, et al. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. Neurobiology of Disease. 58: 132-43. PMID 23726845 DOI: 10.1016/J.Nbd.2013.05.009  0.087
1982 Gold MS, Pottash AC, Sweeney DR, Extein I, Annitto WJ. Opiate detoxification with lofexidine. Drug and Alcohol Dependence. 8: 307-15. PMID 7338185 DOI: 10.1016/0376-8716(81)90040-5  0.087
2011 Gomeni R, Simeoni M, Zvartau-Hind M, Irizarry MC, Austin D, Gold M. Modeling Alzheimer's disease progression using the disease system analysis approach. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 39-50. PMID 21782528 DOI: 10.1016/j.jalz.2010.12.012  0.087
2021 Kerscher M, Fabi S, Fischer T, Gold M, Joseph J, Prager W, Rzany B, Yoelin S, Roll S, Klein G, Maas C. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines. Journal of Drugs in Dermatology : Jdd. 20: 1052-1060. PMID 34636520 DOI: 10.36849/JDD.6377  0.087
2023 Stein Gold L, Lain E, Del Rosso JQ, Gold M, Draelos ZD, Eichenfield LF, Sadick N, Werschler WP, Gooderham MJ, Lupo M. Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials. Journal of the American Academy of Dermatology. PMID 37656094 DOI: 10.1016/j.jaad.2022.08.069  0.087
2011 Avena NM, Gold MS. Sensitivity to alcohol in obese patients: a possible role for food addiction. Journal of the American College of Surgeons. 213: 451; author reply 45. PMID 21871384 DOI: 10.1016/J.Jamcollsurg.2011.05.022  0.087
2004 Gold MS, Byars JA, Frost-Pineda K. Occupational exposure and addictions for physicians: case studies and theoretical implications. The Psychiatric Clinics of North America. 27: 745-53. PMID 15550291 DOI: 10.1016/j.psc.2004.07.006  0.087
2015 Blum K, Badgaiyan RD, Gold MS. Retraction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics. CurēUs. 7: r1. PMID 26451336 DOI: 10.7759/cureus.r1  0.086
2011 Berry JG, Ryan P, Braunack-Mayer AJ, Duszynski KM, Xafis V, Gold MS. A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol. Trials. 12: 1. PMID 21199584 DOI: 10.1186/1745-6215-12-1  0.086
1979 Gold MS, Redmond DE, Kleber HD. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. The American Journal of Psychiatry. 136: 100-2. PMID 364997 DOI: 10.1176/ajp.136.1.100  0.086
2022 Gold MS, Amarasinghe A, Greenhawt M, Kelso JM, Kochhar S, Yu-Hor Thong B, Top KA, Turner PJ, Worm M, Law B. Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine. PMID 36435707 DOI: 10.1016/j.vaccine.2022.11.027  0.086
2005 Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 20: 120-32. PMID 15990426 DOI: 10.1159/000086613  0.086
1984 Washton AM, Gold MS, Pottash AC. Intranasal cocaine addiction. Lancet (London, England). 2: 1374. PMID 6139717 DOI: 10.1016/S0140-6736(83)91143-1  0.086
2007 Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Communicable Diseases Intelligence Quarterly Report. 31: 269-82. PMID 17974219  0.086
2012 Baraf HS, Gold MS, Petruschke RA, Wieman MS. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. The American Journal of Geriatric Pharmacotherapy. 10: 47-60. PMID 22264852 DOI: 10.1016/j.amjopharm.2011.12.002  0.086
2004 Bonhoeffer J, Gold MS, Heijbel H, Vermeer P, Blumberg D, Braun M, de Souza-Brito G, Davis RL, Halperin S, Heininger U, Khuri-Bulos N, Menkes J, Nokleby H. Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 22: 563-8. PMID 14741145  0.086
2012 Gold M, Newhouse PA, Howard D, Kryscio RJ. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology. 78: 1895; author reply 1. PMID 22665146 DOI: 10.1212/Wnl.0B013E31825A45Ec  0.086
2016 Zhu R, Yang T, Kobeissy F, Mouhieddine TH, Raad M, Nokkari A, Gold MS, Wang KK, Mechref Y. The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats. Plos One. 11: e0151034. PMID 27082425 DOI: 10.1371/Journal.Pone.0151034  0.086
1998 Gold MS. Close to Home: Moyers on Addiction Jama: the Journal of the American Medical Association. 280: 2046-2047. DOI: 10.1001/JAMA.280.23.2046  0.086
1991 Miller NS, Giannini AJ, Gold MS, Philomena JA. Drug testing: medical, legal, and ethical issues. Journal of Substance Abuse Treatment. 7: 239-44. PMID 2290186 DOI: 10.1016/0740-5472(90)90047-T  0.086
1995 Gold M, Gleaton T. Cocaine, marijuana, alcohol, and violence: Results of annual high school survey Biological Psychiatry. 37: 627. DOI: 10.1016/0006-3223(95)94536-6  0.086
2014 Davis AA, Edge PJ, Gold MS. New Directions in the Pharmacological Treatment of Food Addiction, Overeating, and Obesity Behavioral Addictions: Criteria, Evidence, and Treatment. 185-213. DOI: 10.1016/B978-0-12-407724-9.00008-2  0.085
2005 Byars JA, Frost-Pineda K, Jacobs WS, Gold MS. Naltrexone augments the effects of nicotine replacement therapy in female smokers. Journal of Addictive Diseases. 24: 49-60. PMID 15784523 DOI: 10.1300/J069v24n02_05  0.085
1984 Dackis CA, Pottash AL, Gold MS, Annitto W. The dexamethasone suppression test for major depression among opiate addicts. The American Journal of Psychiatry. 141: 810-1. PMID 6731627 DOI: 10.1176/AJP.141.6.810  0.085
2005 Pagano J, Graham NA, Frost-Pineda K, Gold MS. The Physician's Role in Recognition and Treatment of Alcohol Dependence and Comorbid Conditions Psychiatric Annals. 35: 473-481. DOI: 10.3928/00485713-20050601-04  0.085
1989 Extein I, Allen S, Gold M, Morales A, Goodnick P, Gross D. Comparison of Bromocriptine and Desipramine in Cocaine Withdrawal Annals of Clinical Psychiatry. 1: 193-197. DOI: 10.3109/10401238909149979  0.085
1989 Miller NS, Millman RB, Gold MS. Suggestions for the dsm-iv criteria for substance use disorders Journal of Nervous and Mental Disease. 177: 316. PMID 2708977 DOI: 10.1097/00005053-198905000-00024  0.085
1984 Sweeney DR, Gold MS, Pottash AL, Martin D. Plasma levels of tricyclic antidepressants in panic disorder. International Journal of Psychiatry in Medicine. 13: 93-6. PMID 6642878 DOI: 10.2190/RGYP-A82A-G5U1-A77W  0.084
2009 Graham NA, Hammond CJ, Gold MS. Drug-induced compulsive behaviors: exceptions to the rule. Mayo Clinic Proceedings. 84: 846-7; author reply . PMID 19720785 DOI: 10.1016/S0025-6196(11)60497-7  0.084
2009 Graham NA, Hammond CJ, Gold MS. Drug-Induced Compulsive Behaviors: Exceptions to the Rule Mayo Clinic Proceedings. 84: 846-847. DOI: 10.4065/84.9.846  0.084
2013 Zhang Y, Zhao H, Qiu S, Tian J, Wen X, Miller JL, von Deneen KM, Zhou Z, Gold MS, Liu Y. Altered functional brain networks in Prader-Willi syndrome. Nmr in Biomedicine. 26: 622-9. PMID 23335390 DOI: 10.1002/Nbm.2900  0.084
2011 Avena NM, Gold MS. Variety and hyperpalatability: are they promoting addictive overeating? The American Journal of Clinical Nutrition. 94: 367-8. PMID 21715513 DOI: 10.3945/ajcn.111.020164  0.084
2005 Flake NM, Bonebreak DB, Gold MS. Estrogen and inflammation increase the excitability of rat temporomandibular joint afferent neurons. Journal of Neurophysiology. 93: 1585-97. PMID 15525813 DOI: 10.1152/jn.00269.2004  0.084
2013 Archer T, Oscar-Berman M, Blum K, Gold M. Epigenetic Modulation of Mood Disorders. Journal of Genetic Syndromes & Gene Therapy. 4. PMID 23565345 DOI: 10.4172/2157-7412.1000120  0.084
2017 Blum K, Badgaiyan RD, Dunston GM, Baron D, Modestino EJ, McLaughlin T, Steinberg B, Gold MS, Gondré-Lewis MC. The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans. Molecular Neurobiology. PMID 28965318 DOI: 10.1007/S12035-017-0758-1  0.083
1983 Extein I, Pottash AL, Gold MS. A possible opioid receptor dysfunction in some depressive disorders. Annals of the New York Academy of Sciences. 398: 113-9. PMID 6297354 DOI: 10.1111/j.1749-6632.1982.tb39484.x  0.083
2004 Frost-Pineda K, VanSusteren T, Gold MS. Are physicians and medical students prepared to educate patients about alcohol consumption? Journal of Addictive Diseases. 23: 1-13. PMID 15132339 DOI: 10.1300/J069V23N02_01  0.083
2006 Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, Gold MS, Porreca F, Strichartz GR. The role of sodium channels in chronic inflammatory and neuropathic pain. The Journal of Pain : Official Journal of the American Pain Society. 7: S1-29. PMID 16632328 DOI: 10.1016/J.Jpain.2006.01.444  0.083
2013 Gold M, McClarren R, Gaughan C. The Lessons Oscar Taught Us: Data Science and Media & Entertainment. Big Data. 1: 105-9. PMID 27442065 DOI: 10.1089/big.2013.0009  0.083
1980 Gold MS, Pottash AL, Sweeney DR, Kleber HD. Effect of methadone dosage on clonidine detoxification efficacy. The American Journal of Psychiatry. 137: 375-6. PMID 7356071 DOI: 10.1176/ajp.137.3.375  0.083
2009 Harriott AM, Gold MS. Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators. Journal of Neurophysiology. 101: 3126-34. PMID 19339455 DOI: 10.1152/jn.91339.2008  0.083
2005 Gold MS, Frost-Pineda K, Melker RJ. Physician suicide and drug abuse. The American Journal of Psychiatry. 162: 1390; author reply 1. PMID 15994734 DOI: 10.1176/appi.ajp.162.7.1390  0.083
2021 Gold M, Andriessen A, Goldberg D, Grover K, Hu S, Lorenc Z, Mandy S. INDIVIDUAL ARTICLE: Algorithm for Nonenergy and Injectable Treatment Pre-/Post-Procedure Measures. Journal of Drugs in Dermatology : Jdd. 20: ss3s-s10s. PMID 34784133 DOI: 10.36849/jdd.1121  0.083
2009 Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report. 33: 365-81. PMID 20301966  0.083
2012 Razafsha M, Behforuzi H, Azari H, Zhang Z, Wang KK, Kobeissy FH, Gold MS. Qualitative versus quantitative methods in psychiatric research. Methods in Molecular Biology (Clifton, N.J.). 829: 49-62. PMID 22231806 DOI: 10.1007/978-1-61779-458-2_3  0.083
2005 GOLD MS, BRANDT JF. Handbook of Clinical Alcoholism Treatment American Journal of Psychiatry. 162: 1038-1039. DOI: 10.1176/APPI.AJP.162.5.1038  0.083
2014 Parrella A, Gold M, Braunack-Mayer A, Baghurst P, Marshall H. Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics. 10: 747-54. PMID 24406315 DOI: 10.4161/hv.27459  0.083
2016 Saloman JL, Scheff NN, Snyder LM, Ross SE, Davis BM, Gold MS. Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 10769-10781. PMID 27798132 DOI: 10.1523/Jneurosci.3480-15.2016  0.082
1982 Extein I, Pottash AL, Gold MS. The thyrotropin-releasing hormone test in the diagnosis of unipolar depression. Psychiatry Research. 5: 311-6. PMID 6798597 DOI: 10.1016/0165-1781(81)90077-9  0.082
1984 Washton AM, Gold MS, Pottash AC, Semlitz L. Adolescent cocaine abusers. Lancet (London, England). 2: 746. PMID 6148489 DOI: 10.1016/S0140-6736(84)92646-1  0.082
2003 Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). Journal of the American College of Cardiology. 42: 627-33. PMID 12932592 DOI: 10.1016/S0735-1097(03)00780-0  0.082
2015 von Deneen KM, Qin W, Liu P, Dong M, Chen P, Xie H, Zhang Y, Gold MS, Liu Y, Tian J. Connectivity Study of the Neuromechanism of Acute Acupuncture Needling during fMRI in "Overweight" Subjects. Evidence-Based Complementary and Alternative Medicine : Ecam. 2015: 384389. PMID 25821486 DOI: 10.1155/2015/384389  0.082
2015 Convertino M, Samoshkin A, Gauthier J, Gold MS, Maixner W, Dokholyan NV, Diatchenko L. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 62: 61-7. PMID 25485963 DOI: 10.1016/J.Pnpbp.2014.11.009  0.082
2008 Kobeissy FH, Warren MW, Ottens AK, Sadasivan S, Zhang Z, Gold MS, Wang KKW. Psychoproteomic analysis of rat cortex following acute methamphetamine exposure Journal of Proteome Research. 7: 1971-1983. PMID 18452277 DOI: 10.1021/Pr800029H  0.082
1996 Gold MS. Drugs and Narcotics in History Jama: the Journal of the American Medical Association. 275: 1364. DOI: 10.1001/JAMA.1996.03530410078039  0.082
2015 Ray M, Gold M. A Retrospective Study of Patient Satisfaction Following a Trial of Nano-fractional RF Treatment. Journal of Drugs in Dermatology : Jdd. 14: 1268-71. PMID 26580876  0.082
1986 Dackis CA, Gold MS. More on self-medication and drug abuse. The American Journal of Psychiatry. 143: 1309-10. PMID 3766797 DOI: 10.1176/ajp.143.10.1309b  0.082
2021 Kobeissy FH, Shakkour Z, Hayek SE, Mohamed W, Gold MS, Wang KKW. Elevation of Pro-inflammatory and Anti-inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury. Journal of Molecular Neuroscience : Mn. PMID 34542809 DOI: 10.1007/s12031-021-01886-8  0.082
2010 Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, ... ... Gold M, et al. A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 1241-56. PMID 20930300 DOI: 10.3233/JAD-2010-100939  0.082
2005 Star JE, Bober D, Gold MS. Double Trouble: Depression and Alcohol Abuse in the Adolescent Patient Psychiatric Annals. 35: 496-502. DOI: 10.3928/00485713-20050601-06  0.081
2020 Kircik LH, Lain E, Gold M, Katz B, Baldwin H, Guenin E, Loncaric A, Pillai R. Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne. Journal of Drugs in Dermatology : Jdd. 19: 1086-1092. PMID 33196747 DOI: 10.36849/JDD.2020.5457  0.081
2011 Gold MS, Graham NA. Food addiction & obesity treatment development. Current Pharmaceutical Design. 17: 1126-7. PMID 21492079 DOI: 10.2174/138161211795656792  0.081
2011 Gold MS, Graham NA. Food addiction & obesity treatment development Current Pharmaceutical Design. 17: 1126-1127.  0.081
2011 Gold MS, Graham NA. Food addiction & obesity treatment development Current Pharmaceutical Design. 17: 1126-1127.  0.081
2023 Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B, Budur K, Gold M. Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study. Brain : a Journal of Neurology. PMID 36730056 DOI: 10.1093/brain/awad024  0.081
2006 Bekker A, Gold M, Ahmed R, Kim J, Rockman C, Jacobovitz G, Riles T, Fisch G. Dexmedetomidine does not increase the incidence of intracarotid shunting in patients undergoing awake carotid endarterectomy. Anesthesia and Analgesia. 103: 955-8. PMID 17000811 DOI: 10.1213/01.ane.0000237288.46912.39  0.081
2009 Gold MS. Dual disorders: nosology, diagnosis, & treatment confusion--chicken or egg? Introduction. Journal of Addictive Diseases. 1-3. PMID 19283969 DOI: 10.1300/J069v26S01_01  0.081
2013 Shriner RL, Gold MS, Mitchell JE. Psychosocial assessment and treatment of bariatric patients Psychiatric Times. 30.  0.081
2008 Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB. Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report. 32: 371-87. PMID 19374268  0.081
2012 Yilmaz-Rastoder E, Gold MS, Hough KA, Gebhart GF, Williams BA. Effect of adjuvant drugs on the action of local anesthetics in isolated rat sciatic nerves. Regional Anesthesia and Pain Medicine. 37: 403-9. PMID 22430023 DOI: 10.1097/Aap.0B013E3182485965  0.081
2003 Behnia A, Zhang L, Charles M, Gold MS. Changes in TrkB-like immunoreactivity in rat trigeminal ganglion after tooth injury. Journal of Endodontics. 29: 135-40. PMID 12597715 DOI: 10.1097/00004770-200302000-00012  0.081
2004 Jacobs WS, Repetto M, Vinson S, Pomm R, Gold MS. Random Urine Testing as an Intervention for Drug Addiction Psychiatric Annals. 34: 781-784. DOI: 10.3928/0048-5713-20041001-18  0.08
2008 Gold MS, Merlo LJ. Initiating abstinence: Rewarding patients' early efforts at sobriety. Psyccritiques. 53. DOI: 10.1037/A0011719  0.08
2022 Riewruja K, Makarczyk M, Alexander PG, Gao Q, Goodman SB, Bunnell BA, Gold MS, Lin H. Experimental models to study osteoarthritis pain and develop therapeutics. Osteoarthritis and Cartilage Open. 4: 100306. PMID 36474784 DOI: 10.1016/j.ocarto.2022.100306  0.08
2022 Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J. Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures. Journal of Alzheimer's Disease : Jad. PMID 35342092 DOI: 10.3233/JAD-215699  0.08
2005 Gold MS, Flake NM. Inflammation-mediated hyperexcitability of sensory neurons. Neuro-Signals. 14: 147-57. PMID 16215297 DOI: 10.1159/000087653  0.08
2011 Boegel K, Gyulai FE, Moore KK, Gold MS. Deleterious impact of a γ-aminobutyric acid type A receptor preferring general anesthetic when used in the presence of persistent inflammation. Anesthesiology. 115: 782-90. PMID 21841466 DOI: 10.1097/ALN.0b013e318215e1cb  0.08
2010 Mahajan D, Roomiani I, Gold MS, Lawrence GL, McIntyre PB, Menzies RI. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Communicable Diseases Intelligence Quarterly Report. 34: 259-76. PMID 21090181  0.08
2015 Blum K, Badgaiyan RD, Agan G, Fratantonio J, Simpatico T, Febo M, Haberstick BC, Smolen A, Gold MS. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction. Journal of Reward Deficiency Syndrome. 1: 65-68. PMID 26052557 DOI: 10.17756/jrds.2015-009  0.08
2015 Blum K, Badgaiyan RD, Gold MS. Correction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics. CurēUs. 7: c1. PMID 26421257 DOI: 10.7759/cureus.c1  0.08
2021 Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, Maaliki D, Wehbe M, Mondello S, Abdelhady S, Shahjouei S, Bizri M, Mechref Y, Gold MS, Dbaibo G, et al. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 1073858420984106. PMID 33393420 DOI: 10.1177/1073858420984106  0.08
1984 Washton AM, Gold MS, Pottash AL. Survey of 500 callers to a national cocaine helpline. Psychosomatics. 25: 771-5. PMID 6494398 DOI: 10.1016/S0033-3182(84)72964-1  0.08
2019 Goldberg D, Andriessen A, Gold M. Radial shockwave therapy for male erectile rejuvenation in a dermatology and/or medical aesthetic practice. Journal of Cosmetic Dermatology. 18: 1596-1600. PMID 31187929 DOI: 10.1111/jocd.13022  0.08
2018 Gold M, Andriessen A, Bader A, Alinsod R, French ES, Guerette N, Kolodchenko Y, Krychman M, Murrmann S, Samuels J. Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation. Journal of Cosmetic Dermatology. 17: 289-297. PMID 29524292 DOI: 10.1111/jocd.12524  0.08
2008 Warren CA, Mok L, Gordon S, Fouad AF, Gold MS. Quantification of neural protein in extirpated tooth pulp. Journal of Endodontics. 34: 7-10. PMID 18155483 DOI: 10.1016/j.joen.2007.09.014  0.08
1980 Extein I, Pottash AL, Gold MS, Cadet J, Sweeney DR, Davies RK, Martin DM. The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression. Psychiatry Research. 2: 199-204. PMID 6774358 DOI: 10.1016/0165-1781(80)90077-3  0.08
2006 Warren MW, Kobeissy FH, Liu MC, Hayes RL, Gold MS, Wang KK. Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury. Journal of Addictive Diseases. 25: 115-23. PMID 17088231 DOI: 10.1300/J069V25N04_11  0.079
1987 Dackis CA, Gold MS, Sweeney DR. The physiology of cocaine craving and 'crashing'. Archives of General Psychiatry. 44: 298-300. PMID 3827524 DOI: 10.1001/ARCHPSYC.1987.01800150122018  0.079
2013 Narurkar VA, Gold M, Shamban AT. Photopneumatic technology used in combination with profusion therapy for the treatment of acne. The Journal of Clinical and Aesthetic Dermatology. 6: 36-40. PMID 24062872  0.079
2009 Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl K, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, et al. Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine. 27: 2289-97. PMID 19061929 DOI: 10.1016/j.vaccine.2008.11.035  0.079
2020 Conrado DJ, Burton J, Hill D, Willis B, Sinha V, Stone J, Coello N, Wang W, Chen D, Nicholas T, Gold M, Hartley E, Kern VD, Romero K, et al. Hippocampal neuroimaging-informed clinical trial enrichment tool for amnestic mild cognitive impairment using open data. Clinical Pharmacology and Therapeutics. PMID 31899810 DOI: 10.1002/cpt.1766  0.079
2000 Jacobs WS, DuPont R, Gold MS. Drug Testing and the DSM-IV Psychiatric Annals. 30: 583-588. DOI: 10.3928/0048-5713-20000901-06  0.079
2012 Empson MB, Tang ML, Pearce LK, Rozen L, Gold MS, Katelaris CH, Langton D, Smart J, Smith WB, Steele RH, Ziegler JB, Maher D. Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency. Journal of Clinical Immunology. 32: 897-906. PMID 22526590 DOI: 10.1007/s10875-011-9641-4  0.079
2020 Kerscher M, Fabi S, Fischer T, Gold M, Joseph J, Prager W, Rzany B, Yoelin S, Roll S, Klein G, Maas C. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines. Journal of Drugs in Dermatology : Jdd. 19: 985-991. PMID 33026771 DOI: 10.36849/JDD.2020.10.36849/JDD.2020.5454  0.078
2011 DeKosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC. Revision of the criteria for Alzheimer’s disease: A symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e1-12. PMID 21322828 DOI: 10.1016/J.Jalz.2010.12.007  0.078
2010 Yuan K, Qin W, Dong M, Liu J, Sun J, Liu P, Zhang Y, Wang W, Wang Y, Li Q, Zhao L, von Deneen KM, Liu Y, Gold MS, Tian J. Gray matter deficits and resting-state abnormalities in abstinent heroin-dependent individuals Neuroscience Letters. 482: 101-105. PMID 20621162 DOI: 10.1016/J.Neulet.2010.07.005  0.078
1984 Extein I, Pottash AL, Gold MS. The TRH test in affective disorders: experience in a private clinical setting. Psychosomatics. 25: 379-80, 383, 385-6 p. PMID 6429709 DOI: 10.1016/S0033-3182(84)73036-2  0.078
2013 Zaenglein AL, Shamban A, Webster G, Del Rosso J, Dover JS, Swinyer L, Stein L, Lin X, Draelos Z, Gold M, Thiboutot D. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. Journal of Drugs in Dermatology : Jdd. 12: 619-25. PMID 23839176  0.078
1988 Jonas JM, Gold MS. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Research. 24: 195-9. PMID 2841709 DOI: 10.1016/0165-1781(88)90062-5  0.078
2009 Liu J, Liang J, Qin W, Tian J, Yuan K, Bai L, Zhang Y, Wang W, Wang Y, Li Q, Zhao L, Lu L, von Deneen KM, Liu Y, Gold MS. Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neuroscience Letters. 460: 72-7. PMID 19450664 DOI: 10.1016/J.Neulet.2009.05.038  0.078
2015 Miller NS, Gold MS. Prescription opioids and addiction Psychiatric Annals. 45: 516-521. DOI: 10.3928/00485713-20151001-07  0.078
2023 Nyambayo PPM, Gold MS, Mehta UC, Clarke S, Manyevere R, Chirinda L, Zifamba EN, Nyamandi T. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Vaccine. 41: 6700-6709. PMID 37805357 DOI: 10.1016/j.vaccine.2023.09.037  0.078
2021 Warren RB, Gold M, Gooderham M, Kircik LH, Lacour JP, Laws P, Liljedahl M, Lynde C, Mørch MH, Sondermann W, Thaçi D. Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase). Journal of Drugs in Dermatology : Jdd. 20: 436-441. PMID 33852252 DOI: 10.36849/JDD.2021.5728  0.077
1995 Gold MS, Miller NS, Stennie K, Populla-Vardi C. Epidemiology of Benzodiazepine Use and Dependence Psychiatric Annals. 25: 146-148. DOI: 10.3928/0048-5713-19950301-06  0.077
2011 Scheff NN, Gold MS. Sex differences in the inflammatory mediator-induced sensitization of dural afferents Journal of Neurophysiology. 106: 1662-1668. PMID 21753025 DOI: 10.1152/jn.00196.2011  0.077
2011 Goss JR, Cascio M, Goins WF, Huang S, Krisky DM, Clarke RJ, Johnson JW, Yokoyama H, Yoshimura N, Gold MS, Glorioso JC. HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 500-6. PMID 21081904 DOI: 10.1038/Mt.2010.246  0.077
2023 Jacobson PB, Mothe A, Levy A, Krakovsky M, Hooker BA, Zhang X, Mollon J, Mordashova Y, Droescher M, Weiss S, Barghorn S, Dreher I, Awwad K, Nimmrich V, Huang L, ... ... Gold M, et al. Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion. Translational Stroke Research. PMID 37326791 DOI: 10.1007/s12975-023-01164-2  0.077
1982 Gold MS, Pottash AL, Extein I. "Symptomless" autoimmune thyroiditis in depression. Psychiatry Research. 6: 261-9. PMID 6810401 DOI: 10.1016/0165-1781(82)90015-4  0.077
2011 Merlo LJ, Ahmedani BK, Barondess DA, Bohnert KM, Gold MS. Alcohol consumption associated with collegiate American football pre-game festivities. Drug and Alcohol Dependence. 116: 242-5. PMID 21288661 DOI: 10.1016/J.Drugalcdep.2010.12.013  0.076
2006 Morgan D, Frost-Pineda K, Gold MS. Medical and Nonmedical Use of Prescription Opioids: Epidemiology and Prevalence Psychiatric Annals. 36. DOI: 10.3928/00485713-20060601-02  0.076
2012 Carnes PJ, Green BA, Merlo LJ, Polles A, Carnes S, Gold MS. PATHOS: a brief screening application for assessing sexual addiction. Journal of Addiction Medicine. 6: 29-34. PMID 21817915 DOI: 10.1097/Adm.0B013E3182251A28  0.076
2022 Loke P, Orsini F, Lozinsky AC, Gold M, O'Sullivan MD, Quinn P, Lloyd M, Ashley SE, Pitkin S, Axelrad C, Metcalfe JR, Su EL, Tey D, Robinson MN, Allen KJ, et al. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial. The Lancet. Child & Adolescent Health. PMID 35123664 DOI: 10.1016/S2352-4642(22)00006-2  0.076
2014 Edge PJ, Gold MS. Potential Role of Addiction Pharmacotherapy in Problematic Eating Behavior Current Addiction Reports. 1: 83-88. DOI: 10.1007/s40429-014-0010-2  0.076
2012 Zhang XL, Mok LP, Lee KY, Charbonnet M, Gold MS. Inflammation-induced changes in BK(Ca) currents in cutaneous dorsal root ganglion neurons from the adult rat. Molecular Pain. 8: 37. PMID 22607137 DOI: 10.1186/1744-8069-8-37  0.076
2021 Jacobson PB, Goody R, Lawrence M, Zhang X, Hooker BA, Pfleeger K, Ziemann A, Locke C, Barraud Q, Droescher M, Bernhard J, Popp A, Boeser P, Huang L, Mollon J, ... ... Gold M, et al. Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemi-compression spinal cord injury in non-human primates. Neurobiology of Disease. 105385. PMID 33991647 DOI: 10.1016/j.nbd.2021.105385  0.076
2016 Liu Q, Gold MS. Opioid-induced Loss of Local Anesthetic Potency in the Rat Sciatic Nerve. Anesthesiology. PMID 27428823 DOI: 10.1097/ALN.0000000000001239  0.076
1984 Dackis CA, Bailey J, Pottash AL, Stuckey RF, Extein IL, Gold MS. Specificity of the DST and the TRH test for major depression in alcoholics. The American Journal of Psychiatry. 141: 680-3. PMID 6424482 DOI: 10.1176/AJP.141.5.680  0.076
2010 Gold MS, McIntyre P. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sexual Health. 7: 320-4. PMID 20719221 DOI: 10.1071/SH09153  0.076
2007 Miller NS, Gold MS. Opiate prescription medication dependence and pain perceptions. Journal of Addictive Diseases. 26: 65-71. PMID 19283975 DOI: 10.1300/J069v26S01_07  0.076
1982 Extein I, Pottash AL, Gold MS, Cowdry RW. Using the protirelin test to distinguish mania from schizophrenia. Archives of General Psychiatry. 39: 77-81. PMID 6798950 DOI: 10.1001/ARCHPSYC.1982.04290010053010  0.075
2010 Gold MS, Gold ST, Herkov M. Drugs And Violence In The USA Encyclopedia of Violence, Peace, and Conflict. 590-606. DOI: 10.1016/B978-012373985-8.00215-4  0.075
2010 Bailey JA, Hurley RW, Gold MS. Crossroads of pain and addiction. Pain Medicine (Malden, Mass.). 11: 1803-18. PMID 21040437 DOI: 10.1111/j.1526-4637.2010.00982.x  0.075
2022 Gale JR, Gedeon JY, Donnelly CJ, Gold MS. Local translation in primary afferents and its contribution to pain. Pain. PMID 35438669 DOI: 10.1097/j.pain.0000000000002658  0.075
1984 Sternbach HA, Fleming J, Extein I, Pottash AL, Gold MS. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients. Psychoneuroendocrinology. 8: 459-62. PMID 6425891 DOI: 10.1016/0306-4530(83)90028-8  0.075
2017 Zhang X, Priest BT, Belfer I, Gold MS. Voltage-gated Na(+) currents in human dorsal root ganglion neurons. Elife. 6. PMID 28508747 DOI: 10.7554/eLife.23235  0.075
2010 Fuller BF, Gold MS, Wang KKW, Ottens AK. Effects of environmental tobacco smoke on adult rat brain biochemistry Journal of Molecular Neuroscience. 41: 165-171. PMID 19960371 DOI: 10.1007/S12031-009-9316-2  0.075
2005 Joranby L, Pineda KF, Gold MS. Addiction to Food and Brain Reward Systems Sexual Addiction & Compulsivity. 12: 201-217. DOI: 10.1080/10720160500203765  0.075
1988 Dackis CA, Gold MS. Psychopharmacology of Cocaine Psychiatric Annals. 18: 528-530. DOI: 10.3928/0048-5713-19880901-09  0.075
1984 Gold MS, Verebey K. The Psychopharmacology of Cocaine Psychiatric Annals. 14: 714-723. DOI: 10.3928/0048-5713-19841001-06  0.075
2015 Henderson SE, Tudares MA, Gold MS, Almarza AJ. Analysis of pain in the rabbit temporomandibular joint after unilateral splint placement. Journal of Oral & Facial Pain and Headache. 29: 193-202. PMID 25905538 DOI: 10.11607/Ofph.1371  0.075
1982 Sternbach HA, Annitto W, Pottash AL, Gold MS. Anorexic effects of naltrexone in man. Lancet (London, England). 1: 388-9. PMID 6120359 DOI: 10.1016/S0140-6736(82)91407-6  0.075
1998 Miller NS, Swift RM, Gold MS. Health Care Economics for Integrated Addiction Treatment in Clinical Settings Psychiatric Annals. 28: 682-689. DOI: 10.3928/0048-5713-19981201-06  0.074
2000 Gold M, Tullis L. 514. Identifying alcohol abuse: MDs and the cage Biological Psychiatry. 47: S156. DOI: 10.1016/S0006-3223(00)00783-6  0.074
2010 Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, Craft S, Landreth G, Linnamägi U, Sawchak S. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dementia and Geriatric Cognitive Disorders. 30: 131-46. PMID 20733306 DOI: 10.1159/000318845  0.074
2010 Gold M, Dugdale S, Woodman RJ, McCaul KA. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage Vaccine. 28: 4308-4311. PMID 20430123 DOI: 10.1016/j.vaccine.2010.04.021  0.074
1986 Cocores JA, Schlesinger LB, Gold MS. A review of the EEG literature on Ganser's syndrome International Journal of Psychiatry in Medicine. 16: 59-65. PMID 3522461  0.074
2008 Merlo LJ, Gold MS. Promoting Self-Change from Addictive Behaviors: Practical Implications for Policy, Prevention, and Treatment Jama. 299: 838-840. DOI: 10.1001/Jama.299.7.838-B  0.074
1983 Dackis CA, Gold MS. Opiate addiction and depression--cause or effect? Drug and Alcohol Dependence. 11: 105-9. PMID 6851846 DOI: 10.1016/0376-8716(83)90105-9  0.074
2003 Gold MS, Frost-Pineda K, Jacobs WS. Overeating, Binge Eating, and Eating Disorders as Addictions Psychiatric Annals. 33: 117-122. DOI: 10.3928/0048-5713-20030201-08  0.074
2008 Gold MS, Brezing CA. A Marriage of Psychology and Economics: New Approaches to the Study of Disordered Gambling and Addiction Psyccritiques. 53. DOI: 10.1037/A0013699  0.074
2008 Linde C, Gold M, Abraham WT, Daubert JC. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. Congestive Heart Failure (Greenwich, Conn.). 14: 66-74. PMID 18401214 DOI: 10.1111/j.1751-7133.2008.07613.x  0.074
1988 Herridge P, Gold MS. The New User of Cocaine: Evidence from 800-COCAINE Psychiatric Annals. 18: 521-522. DOI: 10.3928/0048-5713-19880901-07  0.074
2013 Karantzoulis S, Novitski J, Gold M, Randolph C. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 837-44. PMID 23867976 DOI: 10.1093/Arclin/Act057  0.073
2005 Gold MS. This Issue: Alcohol Abuse Psychiatric Annals. 35: 458-460. DOI: 10.3928/00485713-20050601-02  0.073
2011 Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J, Gold M, Nissen M, Elliott EJ, Burgess M, Booy R. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood. 96: 453-6. PMID 21349886 DOI: 10.1136/adc.2010.206037  0.073
2019 Duszynski KM, Pratt NL, Lynch JW, Berry JG, Gold MS. Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine. 37: 280-288. PMID 30503081 DOI: 10.1016/j.vaccine.2018.11.025  0.073
1980 Gold MS, Pottash AL, Ryan N, Sweeney DR, Davies RK, Martin DM. TRH-induced TSH response in unipolar, bipolar, and secondary depressions: possible utility in clinical assessment and differential diagnosis. Psychoneuroendocrinology. 5: 147-55. PMID 6771792 DOI: 10.1016/0306-4530(80)90017-7  0.073
2020 Moy JK, Hartung JE, Duque MG, Friedman R, Nagarajan V, Loeza-Alcocer E, Koerber HR, Christoph T, Schröder W, Gold MS. Distribution of functional opioid receptors in human dorsal root ganglion neurons. Pain. PMID 32102022 DOI: 10.1097/J.Pain.0000000000001846  0.073
2022 Collinson AC, Moore L, Cheung A, Gold MS, Goh DW. Subcutaneous nodules following vaccination. Journal of Paediatrics and Child Health. PMID 35137488 DOI: 10.1111/jpc.15900  0.073
2013 Avena NM, Murray S, Gold MS. The next generation of obesity treatments: beyond suppressing appetite. Frontiers in Psychology. 4: 721. PMID 24130541 DOI: 10.3389/Fpsyg.2013.00721  0.073
2023 Schachner LA, Alexis AF, Andriessen A, Berson D, Gold M, Goldberg DJ, Hu S, Keri J, Kircik L, Woolery-Lloyd H. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. Journal of Cosmetic Dermatology. PMID 37605504 DOI: 10.1111/jocd.15946  0.072
1985 Extein I, Pottash AL, Gold MS. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression. Psychoneuroendocrinology. 10: 281-8. PMID 4059475 DOI: 10.1016/0306-4530(85)90005-8  0.072
2020 Perez Chacon G, Estcourt MJ, Totterdell J, Campbell DE, Perrett KP, Marsh JA, Richmond PC, Wood N, Gold MS, Holt PG, Waddington CS, Snelling TL. OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. Bmj Open. 10: e042838. PMID 33334840 DOI: 10.1136/bmjopen-2020-042838  0.072
2017 Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R. Adverse events following primary and secondary immunisation with whole-cell pertussis: a systematic review protocol. Bmj Open. 7: e012945. PMID 28122832 DOI: 10.1136/bmjopen-2016-012945  0.072
1977 Gold MS, Donabedian RK, Dillard M, Slobetz FW, Riordan CE, Kleber HD. Antipsychotic effect of opiate agonists. Lancet (London, England). 2: 398-9. PMID 70602 DOI: 10.1016/S0140-6736(77)90319-1  0.072
2022 Li ZA, Sant S, Cho SK, Goodman SB, Bunnell BA, Tuan RS, Gold MS, Lin H. Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential. Trends in Biotechnology. PMID 35995600 DOI: 10.1016/j.tibtech.2022.07.011  0.072
2014 Zhang Y, Liu J, Yao J, Ji G, Qian L, Wang J, Zhang G, Tian J, Nie Y, Zhang YE, Gold MS, Liu Y. Obesity: pathophysiology and intervention. Nutrients. 6: 5153-83. PMID 25412152 DOI: 10.3390/Nu6115153  0.071
2014 Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, ... ... Gold M, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85. PMID 24873720 DOI: 10.1016/S1474-4422(14)70088-2  0.071
2019 Gold M, Ablon G, Andriessen A, Goldberg D, Hooper D, Mandy S. Facial cleansing with a sonic brush-A review of the literature and current recommendations. Journal of Cosmetic Dermatology. 18: 686-691. PMID 30985993 DOI: 10.1111/jocd.12906  0.071
2005 Warren MW, Kobeissy FH, Liu MC, Hayes RL, Gold MS, Wang KKW. Concurrent calpain and caspase-3 mediated proteolysis of αII-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injury Life Sciences. 78: 301-309. PMID 16125733 DOI: 10.1016/J.Lfs.2005.04.058  0.071
2022 Tunbridge M, Perkins G, Lee M, Salehi T, Yuson C, Le A, Ryoo D, Kette F, Smith W, Gold M, Hissaria P. COVID vaccination can be completed in subjects with a history of allergic reactions to the vaccines or their components - experience from a specialist clinic in South Australia. Internal Medicine Journal. PMID 35848521 DOI: 10.1111/imj.15888  0.071
2022 Palmer DJ, Sullivan TR, Campbell DE, Nanan R, Gold MS, Hsu PS, Netting MJ, McWilliam V, Koplin JJ, Perrett KP, Quinn P, O'Sullivan M, Prescott SL, Grivell R, Makrides M. PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes. Bmj Open. 12: e056925. PMID 35697444 DOI: 10.1136/bmjopen-2021-056925  0.071
1989 Miller NS, Gold MS. Suggestions for changes in DSM-III-R criteria for substance use disorders. The American Journal of Drug and Alcohol Abuse. 15: 223-30. PMID 2729228 DOI: 10.3109/00952998909092722  0.071
1980 Gold MS, Pottash AL, Extein I, Sweeney DR. Dexamethasone suppression tests in depression and response to treatment. Lancet (London, England). 1: 1190. PMID 6104009 DOI: 10.1016/S0140-6736(80)91647-5  0.071
2007 Warren MW, Gold MS. The relationship between obesity and drug use. The American Journal of Psychiatry. 164: 1268; author reply 1. PMID 17671293 DOI: 10.1176/APPI.AJP.2007.07030388  0.071
2021 Hartung JE, Moy JK, Loeza-Alcocer E, Nagarajan V, Jostock R, Christoph T, Schroeder W, Gold MS. Voltage gated calcium channels in human dorsal root ganglion neurons. Pain. PMID 34510139 DOI: 10.1097/j.pain.0000000000002465  0.071
2020 Gold MS, MacDonald NE, McMurtry CM, Balakrishnan MR, Heininger U, Menning L, Benes O, Pless R, Zuber PLF. Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization. Vaccine. PMID 32131975 DOI: 10.1016/j.vaccine.2020.02.046  0.071
2004 Gold MS, Traub RJ. Cutaneous and colonic rat DRG neurons differ with respect to both baseline and PGE2-induced changes in passive and active electrophysiological properties. Journal of Neurophysiology. 91: 2524-31. PMID 14736864 DOI: 10.1152/jn.00866.2003  0.071
2016 Holt PG, Snelling T, White OJ, Sly PD, DeKlerk N, Carapetis J, Biggelaar AV, Wood N, McIntyre P, Gold M. Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine? Vaccine. PMID 27265452 DOI: 10.1016/j.vaccine.2016.05.048  0.071
2019 Estcourt MJ, Campbell DE, Gold MS, Richmond P, Allen KJ, Quinn HE, Marsh JA, Peters RL, Valerio C, Dai D, Waddington CS, Wood NJ, McIntyre PB, Holt PG, Snelling TL. Whole cell pertussis vaccination and decreased risk of IgE-mediated food allergy: a nested case-control study. The Journal of Allergy and Clinical Immunology. in Practice. PMID 31891824 DOI: 10.1016/j.jaip.2019.12.020  0.071
1986 Dackis CA, Gold MS, Pottash AL, Sweeney DR. Evaluating depression in alcoholics. Psychiatry Research. 17: 105-9. PMID 3961028 DOI: 10.1016/0165-1781(86)90065-X  0.07
2017 Kobeissy FH, Guingab-Cagmat J, Bruijnzeel AW, Gold MS, Wang K. Effect of Second-Hand Tobacco Smoke on the Nitration of Brain Proteins: A Systems Biology and Bioinformatics Approach. Methods in Molecular Biology (Clifton, N.J.). 1598: 353-372. PMID 28508372 DOI: 10.1007/978-1-4939-6952-4_18  0.07
2020 Najjar SA, Ejoh LL, Loeza-Alcocer E, Edwards BS, Smith-Edwards KM, Epouhe AY, Gold MS, Davis BM, Albers KM. Optogenetic inhibition of colon epithelium reduces hypersensitivity in a mouse model of inflammatory bowel disease. Pain. PMID 33048854 DOI: 10.1097/j.pain.0000000000002110  0.07
2009 Cocores JA, Gold MS. The Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic. Medical Hypotheses. 73: 892-9. PMID 19643550 DOI: 10.1016/j.mehy.2009.06.049  0.07
2018 Estcourt MJ, Marsh JA, Campbell DE, Gold MS, Allen KJ, Richmond P, Waddington CS, Snelling TL. Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children. Bmj Open. 8: e020232. PMID 29391374 DOI: 10.1136/bmjopen-2017-020232  0.07
2013 Berry JG, Ryan P, Duszynski KM, Braunack-Mayer AJ, Carlson J, Xafis V, Gold MS. Parent perspectives on consent for the linkage of data to evaluate vaccine safety: a randomised trial of opt-in and opt-out consent. Clinical Trials (London, England). 10: 483-94. PMID 23568940 DOI: 10.1177/1740774513480568  0.07
2002 Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, Porreca F. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain. 95: 143-52. PMID 11790477 DOI: 10.1016/S0304-3959(01)00391-8  0.07
2011 Klahr NJ, Wright P, Lu G, Merlo L, Zhang Y, He G, Gold MS, Liu Y. Investigating the effects of low dose alcohol on neural timing using functional MRI. Journal of Magnetic Resonance Imaging : Jmri. 34: 1045-52. PMID 21928385 DOI: 10.1002/Jmri.22747  0.07
1995 GOLD MS. Opioid Peptides in Substance Abuse American Journal of Psychiatry. 152: 945-947. DOI: 10.1176/AJP.152.6.945  0.07
2004 Lai J, Porreca F, Hunter JC, Gold MS. Voltage-gated sodium channels and hyperalgesia. Annual Review of Pharmacology and Toxicology. 44: 371-97. PMID 14744251 DOI: 10.1146/annurev.pharmtox.44.101802.121627  0.07
2019 Singh JP, Abraham WT, Auricchio A, Delnoy PP, Gold M, Reddy VY, Sanders P, Lindenfeld J, Rinaldi CA. Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. American Heart Journal. 217: 13-22. PMID 31472360 DOI: 10.1016/j.ahj.2019.04.002  0.07
1986 Dackis CA, Stuckey RF, Gold MS, Pottash AL. Dexamethasone suppression test testing of depressed alcoholics. Alcoholism, Clinical and Experimental Research. 10: 59-60. PMID 3515993 DOI: 10.1111/J.1530-0277.1986.TB05615.X  0.07
2007 Gold M. Study design factors and patient demographics and their effect on the decline of placebo-treated subjects in randomized clinical trials in Alzheimer's disease. The Journal of Clinical Psychiatry. 68: 430-8. PMID 17388715 DOI: 10.4088/jcp.v68n0313  0.069
2008 Merlo LJ, Gold MS. Increased assessment and monitoring needed for patients receiving methadone. The American Journal of Medicine. 121: e23; author repply e. PMID 18456018 DOI: 10.1016/J.Amjmed.2008.01.037  0.069
2017 Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND. Correction: Chronic Methamphetamine Effects on Brain Structure and Function in Rats. Plos One. 12: e0172080. PMID 28178354 DOI: 10.1371/Journal.Pone.0172080  0.069
2021 Loeza-Alcocer E, Gold MS. Peripheral GABAA receptor signaling contributes to visceral hypersensitivity in a mouse model of colitis. Pain. PMID 34726659 DOI: 10.1097/j.pain.0000000000002526  0.069
1980 Pottash AL, Gold MS, Pottenger M, Prusoff BA. Hedonic deficit in chronic schizophrenia. International Journal of Psychiatry in Medicine. 9: 227-37. PMID 757211 DOI: 10.2190/CVLD-MW8R-DD9Y-15VR  0.069
2021 Pineda-Farias JB, Loeza-Alcocer E, Nagarajan V, Gold MS, Sekula R. Mechanisms underlying the selective therapeutic efficacy of carbamazepine for attenuation of trigeminal nerve injury pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34446571 DOI: 10.1523/JNEUROSCI.0547-21.2021  0.069
1995 Gold M, Gleaton T. A new marijuana use epidemic: Marked marijuana use increases in annual (1994) survey Biological Psychiatry. 37: 628. DOI: 10.1016/0006-3223(95)94539-9  0.069
2020 Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, ... ... Gold M, et al. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nature Medicine. PMID 32094924 DOI: 10.1038/S41591-020-0757-Z  0.069
2015 Blum K, Braverman ER, Waite RL, Archer T, Thanos PK, Badgaiyan R, Febo M, Dushaj K, Li M, Gold MS. Neuroquantum theories of psychiatric genetics: Can physical forces induce epigenetic influence on future genomes? Neuroquantology. 13: 90-103. DOI: 10.14704/Nq.2015.13.1.799  0.068
2016 Weiss M, Mahoney AM, Gold M, Lawrence N. Leg Rejuvenation: A Combination Approach: A Review and Our Experience. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 42: S131-8. PMID 27128239 DOI: 10.1097/DSS.0000000000000753  0.068
2017 Lim G, Farrell LM, Facco FL, Gold MS, Wasan AD. Labor Analgesia as a Predictor for Reduced Postpartum Depression Scores: A Retrospective Observational Study. Anesthesia and Analgesia. PMID 29239949 DOI: 10.1213/ANE.0000000000002720  0.068
1998 Miller NS, Gold MS. Comorbid cigarette and alcohol addiction: epidemiology and treatment. Journal of Addictive Diseases. 17: 55-66. PMID 9549603 DOI: 10.1300/J069V17N01_06  0.068
1983 Fleming JE, Extein I, Sternbach HA, Pottash AL, Gold MS. The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression. Psychiatry Research. 9: 53-8. PMID 6412261 DOI: 10.1016/0165-1781(83)90089-6  0.068
Hide low-probability matches.